<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-archivearticle1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Diabetes Res</journal-id><journal-id journal-id-type="iso-abbrev">J Diabetes Res</journal-id><journal-id journal-id-type="publisher-id">JDR</journal-id><journal-title-group><journal-title>Journal of Diabetes Research</journal-title></journal-title-group><issn pub-type="ppub">2314-6745</issn><issn pub-type="epub">2314-6753</issn><publisher><publisher-name>Hindawi Publishing Corporation</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">4630397</article-id><article-id pub-id-type="doi">10.1155/2015/515307</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title>Mechanistic Contributions of Biological Cofactors in Islet Amyloid Polypeptide Amyloidogenesis</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Nguyen</surname><given-names>Phuong Trang</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref><xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Andraka</surname><given-names>Nagore</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref><xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref><xref ref-type="aff" rid="I3">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>De Carufel</surname><given-names>Carole Anne</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref><xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Bourgault</surname><given-names>Steve</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref><xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref><xref ref-type="corresp" rid="cor1">
<sup>*</sup>
</xref></contrib></contrib-group><aff id="I1"><sup>1</sup>Department of Chemistry, Pharmaqam, University of Quebec in Montreal, Montreal, QC, Canada H3C 3P8</aff><aff id="I2"><sup>2</sup>Quebec Network for Research on Protein Function, Structure, and Engineering (PROTEO), Canada</aff><aff id="I3"><sup>3</sup>Biophysics Unit (CSIC, UPV/EHU) and Department of Biochemistry and Molecular Biology, Faculty of Science and Technology, University of the Basque Country, 48080 Bilbao, Spain</aff><author-notes><corresp id="cor1">*Steve Bourgault: <email>bourgault.steve@uqam.ca</email></corresp><fn fn-type="other"><p>Academic Editor: Ehud Gazit</p></fn></author-notes><pub-date pub-type="ppub"><year>2015</year></pub-date><pub-date pub-type="epub"><day>20</day><month>10</month><year>2015</year></pub-date><volume>2015</volume><elocation-id>515307</elocation-id><history><date date-type="received"><day>5</day><month>11</month><year>2014</year></date><date date-type="rev-recd"><day>26</day><month>1</month><year>2015</year></date><date date-type="accepted"><day>9</day><month>2</month><year>2015</year></date></history><permissions><copyright-statement>Copyright &#169; 2015 Phuong Trang Nguyen et al.</copyright-statement><copyright-year>2015</copyright-year><license xlink:href="https://creativecommons.org/licenses/by/3.0/"><license-p>This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>Type II diabetes mellitus is associated with the deposition of fibrillar aggregates in pancreatic islets. The major protein component of islet amyloids is the glucomodulatory hormone islet amyloid polypeptide (IAPP). Islet amyloid fibrils are virtually always associated with several biomolecules, including apolipoprotein E, metals, glycosaminoglycans, and various lipids. IAPP amyloidogenesis has been originally perceived as a self-assembly homogeneous process in which the inherent aggregation propensity of the peptide and its local concentration constitute the major driving forces to fibrillization. However, over the last two decades, numerous studies have shown a prominent role of amyloid cofactors in IAPP fibrillogenesis associated with the etiology of type II diabetes. It is increasingly evident that the biochemical microenvironment in which IAPP amyloid formation occurs and the interactions of the polypeptide with various biomolecules not only modulate the rate and extent of aggregation, but could also remodel the amyloidogenesis process as well as the structure, toxicity, and stability of the resulting fibrils.</p></abstract></article-meta></front><body><sec id="sec1"><title>1. Introduction</title><p>Several diseases are associated with the extracellular deposition of protein aggregates, including the Alzheimer's disease, the transthyretin, and light chain amyloidoses as well as type II diabetes [<xref rid="B1" ref-type="bibr">1</xref>]. Accumulation of insoluble protein in the extracellular space results from the aberrant assembly of proteins into aggregates, usually with a quaternary structure rich in cross-<italic>&#946;</italic>-sheets, known as amyloid [<xref rid="B2" ref-type="bibr">2</xref>]. The causative link between the observed pathophysiology and amyloid formation is now supported by numerous genetic, biochemical, and pharmacological studies [<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B3" ref-type="bibr">3</xref>&#8211;<xref rid="B5" ref-type="bibr">5</xref>]. More than 30 human endogenous proteins have been identified as precursors of amyloid fibrils whose deposition is associated with tissue degeneration. Although these amyloidogenic precursors share no sequence and native state structure homologies, amyloids extracted from patients share several structural, chemical, and biological features, including an extensive cross <italic>&#946;</italic>-sheet structure and the capacity to bind specific dyes, such as Congo Red and thioflavin T (ThT) [<xref rid="B1" ref-type="bibr">1</xref>]. Particularly, fibrils are virtually always associated with nonfibrillar biomolecules, including the serum amyloid P component [<xref rid="B6" ref-type="bibr">6</xref>], apolipoprotein E [<xref rid="B7" ref-type="bibr">7</xref>], collagen [<xref rid="B8" ref-type="bibr">8</xref>], metals [<xref rid="B9" ref-type="bibr">9</xref>], glycosaminoglycans (GAGs) [<xref rid="B10" ref-type="bibr">10</xref>], and various lipids [<xref rid="B11" ref-type="bibr">11</xref>]. These cofactors were initially regarded as accessory molecules and/or contaminants of the amyloids. However, over the last two decades, several studies have instead highlighted that these amyloid cofactors can promote and/or modulate the amyloidogenic process. In this view, amyloid formation might not be simply a consequence of a protein misfolding event but may be more a consequence of the interaction of the amyloidogenic protein precursor with extrinsic factors and/or its (bio)chemical microenvironment [<xref rid="B9" ref-type="bibr">9</xref>].</p><p>The deposition of amyloid fibrils in the islets of Langerhans of patients afflicted by type II diabetes was originally described at the beginning of last century [<xref rid="B12" ref-type="bibr">12</xref>]. Over the 20th century, it was confirmed that islet hyalinization, that is, tissue degeneration into a classy translucent material, was closely associated with diabetes mellitus, particularly in elderly individuals [<xref rid="B13" ref-type="bibr">13</xref>, <xref rid="B14" ref-type="bibr">14</xref>]. It is only in 1987 that the major component of islet amyloids was identified as a 37-residue peptide, the islet amyloid polypeptide (IAPP) [<xref rid="B15" ref-type="bibr">15</xref>] or amylin [<xref rid="B16" ref-type="bibr">16</xref>]. As IAPP is coexpressed, copackaged, and cosecreted with insulin by the pancreatic <italic>&#946;</italic>-cells [<xref rid="B17" ref-type="bibr">17</xref>], the overproduction of insulin often associated with type II diabetes will lead to an increased release of IAPP. This elevated local concentration of IAPP in the islets of Langerhans should, in theory, promote the formation of amyloid. Nonetheless, although IAPP is expressed in nondiabetic subjects at levels higher than those required to form amyloids<italic> in vitro</italic> [<xref rid="B18" ref-type="bibr">18</xref>], IAPP rarely deposits in the pancreas of normal individuals [<xref rid="B19" ref-type="bibr">19</xref>]. This suggests that IAPP concentration is not the critical factor contributing to its aggregation and proposes that other elements could play a determinant role in the amyloidogenic process and, accordingly, in the etiology of type II diabetes.</p><p>In this review, we will initially describe IAPP structure and normal physiological functions and briefly present its proposed mechanisms of aggregation. We will mainly focus on the roles of amyloid cofactors and/or the biological environment in amyloid formation. As the role of model membranes in IAPP fibrillogenesis has been previously discussed in outstanding reviews [<xref rid="B20" ref-type="bibr">20</xref>&#8211;<xref rid="B23" ref-type="bibr">23</xref>], the present paper will mainly put an emphasis on other factors, such as GAGs and metals. Finally, we will discuss the potential roles of amyloid cofactors in <italic>&#946;</italic>-cells degeneration associated with IAPP aggregation and amyloid deposition.</p></sec><sec id="sec2"><title>2. Islet Amyloid Polypeptide</title><p>Characterization of the peptide isolated from human islet amyloids led to the identification of a C-<italic>&#945;</italic>-amidated 37-residue peptide [<xref rid="B15" ref-type="bibr">15</xref>]. IAPP is expressed as an 89-residue polypeptide, called preproIAPP, containing a 22-residue signal peptide that is cleaved off in the reticulum endoplasmic to form proIAPP [<xref rid="B24" ref-type="bibr">24</xref>]. Subsequent posttranslational modifications of proIAPP involving the action of prohormone convertase (PC) enzymes and carboxypeptidase E (CPE) lead to the formation of a C-<italic>&#945;</italic>-amidated, cyclized, and biologically active peptide [<xref rid="B25" ref-type="bibr">25</xref>]. The primary structure of IAPP has been determined in several mammalian species, including monkey, dog, mouse, and rat (<xref ref-type="fig" rid="fig1">Figure 1(a)</xref>). The N- and C-terminal regions of IAPP have been well conserved in all mammalian species, whereas the central 21&#8211;29 domain is more variable and shows important interspecies variations. Particularly, IAPP sequences found in mice and rat contain Pro residues at positions 25, 28, and 29 whereas the human sequence encompasses Ala, Ser, and Ser, respectively [<xref rid="B26" ref-type="bibr">26</xref>]. This variation is significant for the amyloidogenesis process, as rat (rIAPP) and mice (mIAPP) peptide are less prone to aggregation and these two species do not form islet amyloids [<xref rid="B27" ref-type="bibr">27</xref>]. In solution, human IAPP (hIAPP) exhibits a conformational ensemble mainly populated by disordered conformations, although it diverges from an absolute random coil by the presence of local and transient ordered structures [<xref rid="B28" ref-type="bibr">28</xref>]. For instance, the segment 5&#8211;19 of rIAPP, which exhibits a high homology with hIAPP, appears to transiently populate <italic>&#945;</italic>-helix in its monomeric form [<xref rid="B28" ref-type="bibr">28</xref>, <xref rid="B29" ref-type="bibr">29</xref>]. Besides, from molecular dynamics simulations, it was reported that hIAPP monomers could form ordered and extended <italic>&#946;</italic>-hairpins [<xref rid="B29" ref-type="bibr">29</xref>]. In presence of lipid membrane models or organic solvent, such as hexafluoroisopropanol (HFIP), hIAPP readily adopts an <italic>&#945;</italic>-helical conformation (<xref ref-type="fig" rid="fig1">Figure 1(b)</xref>) [<xref rid="B30" ref-type="bibr">30</xref>]. For example, in dodecylphosphocholine (DPC) micelles, rIAPP exhibits a structure characterized by a single helical region spanning from residues Ala-5 to Ser-23 followed by a disordered C-terminal domain [<xref rid="B31" ref-type="bibr">31</xref>]. When incubated with sodium dodecyl sulfate (SDS) micelles, hIAPP forms, instead, two <italic>&#945;</italic>-helical segments spanning from residues Ala-7 to Val-17 and Asn-21 to Ser-28 and a short 3<sub>10</sub> helix from Gly-33 to Asn-35 [<xref rid="B32" ref-type="bibr">32</xref>]. Both rat and human 1&#8211;19 IAPP fragments show a helical conformation in DPC micelles, although they adopt different orientation on the micelle surface [<xref rid="B33" ref-type="bibr">33</xref>].</p><p>IAPP is a member of the calcitonin peptide family, which includes calcitonin, calcitonin-gene-related peptides (CGRPs), and adrenomedullin [<xref rid="B34" ref-type="bibr">34</xref>]. IAPP shares 46% sequence homology with CGRP and 20% with calcitonin. These peptide hormones mediate their biological activities by binding and activating class B G protein-coupled receptors (GPCRs) [<xref rid="B35" ref-type="bibr">35</xref>]. Interestingly, no specific GPCR<italic> per se</italic> for IAPP has been identified so far. Instead, IAPP shares the calcitonin receptor (CT) with calcitonin, although it binds to CT with a relatively low affinity. The function, pharmacology, and selectivity of the CT receptor are altered by its association with receptor activity-modifying proteins (RAMPs). RAMPs constitute a family of single transmembrane proteins with 3 members: RAMP<sub>1</sub>, RAMP<sub>2</sub>, and RAMP<sub>3</sub> [<xref rid="B36" ref-type="bibr">36</xref>]. Association of the CT receptor with RAMP<sub>1</sub> or RAMP<sub>3</sub> changes the selectivity of the receptor and increases significantly the affinity for IAPP [<xref rid="B37" ref-type="bibr">37</xref>]. IAPP specific binding sites were initially identified in the brain and the renal cortex and have now been identified in several peripheral tissues [<xref rid="B38" ref-type="bibr">38</xref>]. Under normal physiological conditions, IAPP is cosecreted with insulin from <italic>&#946;</italic>-pancreatic cells in response to an elevated blood glucose concentration. In skeletal muscles, IAPP inhibits basal and insulin-stimulated glycogen synthesis, resulting in an increase of glucose-6-phosphate level [<xref rid="B25" ref-type="bibr">25</xref>]. Studies have also shown that IAPP suppresses glucagon secretion, decreases gastric emptying, and induces satiety [<xref rid="B25" ref-type="bibr">25</xref>, <xref rid="B39" ref-type="bibr">39</xref>, <xref rid="B40" ref-type="bibr">40</xref>]. IAPP may also be involved in the process of tissues calcification and could play a critical role in the inhibition of bone resorption [<xref rid="B41" ref-type="bibr">41</xref>]. Like other members of the calcitonin family, IAPP is a potent vasodilator and causes systemic hypotension and tachycardia [<xref rid="B25" ref-type="bibr">25</xref>, <xref rid="B42" ref-type="bibr">42</xref>]. However, these effects were observed at much higher concentrations than the circulating physiological concentration of IAPP, normally ranging in the low picomolar (3&#8211;20&#8201;pM) [<xref rid="B23" ref-type="bibr">23</xref>, <xref rid="B43" ref-type="bibr">43</xref>]. Thus, these effects should be interpreted with precaution since they could result from the activation of the CT receptor not associated with a RAMP and/or of the CT-receptor-like receptor. Taken together, the biological functions of IAPP are still far from being clearly understood [<xref rid="B25" ref-type="bibr">25</xref>].</p></sec><sec id="sec3"><title>3. IAPP Amyloid: Structure and Mechanisms of Formation</title><sec id="sec3.1"><title>3.1. Structure of IAPP Amyloid Fibrils</title><p>Amyloid fibrils, including IAPP amyloids, are highly ordered assemblies that predominantly adopt a characteristic cross-<italic>&#946;</italic>-sheet quaternary structure [<xref rid="B44" ref-type="bibr">44</xref>]. This structural motif provides the most favorable organization for these supramolecular assemblies and can accommodate a high diversity of polypeptide sequences [<xref rid="B45" ref-type="bibr">45</xref>]. Amyloids are characterized by an X-ray diffraction pattern with two characteristic signals, a clear reflection at 4.7&#8201;&#197; along the direction of the fibril, and a diffuse reflection around 10&#8201;&#197; perpendicular to the fibril axis (<xref ref-type="fig" rid="fig2">Figure 2</xref>). By atomic force microscopy (AFM) and electron microscopy (EM), amyloids extracted from patients or prepared<italic> in vitro</italic> appear as long (0.5 to 10&#8201;<italic>&#956;</italic>m) and unbranched filaments having 4 to 15&#8201;nm of diameter [<xref rid="B1" ref-type="bibr">1</xref>] (<xref ref-type="fig" rid="fig2">Figure 2</xref>). Until recently, the structure of amyloids at the atomic level was unclear, since amyloids do not form crystals and are insoluble, precluding their characterization by X-ray crystallography and solution nuclear magnetic resonance (NMR). Thanks to recent advances in techniques such as solid state NMR [<xref rid="B44" ref-type="bibr">44</xref>] and the ability of growing nanocrystals of peptide fragments [<xref rid="B46" ref-type="bibr">46</xref>], it has been possible to elucidate the structure of several amyloids. These approaches, along with cryoelectron microscopy, have suggested that amyloid fibrils present a core sharing several characteristics. Nonetheless, it has also been reported that amyloids have significant structural differences [<xref rid="B44" ref-type="bibr">44</xref>]. These differences can be seen in (i) the length of the <italic>&#946;</italic>-strands, (ii) the arrangement (parallel versus antiparallel) of the constituting sheets of the strand, (iii) the length and arrangement of structures which are not inside the fibril core, and (iv) the number of <italic>&#946;</italic>-sheets per each protofilament [<xref rid="B1" ref-type="bibr">1</xref>]. Thus, although amyloid fibrils display similar characteristics, a marked polymorphism exists not only between fibrils from different precursors, but also between amyloids assembled from the same polypeptide but in different conditions [<xref rid="B47" ref-type="bibr">47</xref>].</p><p>The atomic structure of IAPP in its fibrillar form has been studied by a variety of approaches, including solid state NMR, X-ray crystallography, and electron paramagnetic resonance (EPR) spectroscopy. According to the technique used and/or the conditions in which IAPP amyloids were assembled, three main atomic models have been proposed. Firstly, in the model derived from solid state NMR study, IAPP protofibrils consist of two columns of symmetry related monomers packed against each other [<xref rid="B48" ref-type="bibr">48</xref>]. Each polypeptide monomer adopts a U-shaped structure and contains two <italic>&#946;</italic>-strands connected by a bend-loop. These <italic>&#946;</italic>-strands comprise, respectively, residues 8&#8211;17 and 28&#8211;37 whereas the loop involves residues 18&#8211;27 [<xref rid="B48" ref-type="bibr">48</xref>]. Residues 1 to 7 do not participate in the <italic>&#946;</italic>-structure, most likely because of the conformational constraints imposed by the disulfide bridge [<xref rid="B23" ref-type="bibr">23</xref>]. Secondly, the Eisenberg group has proposed a model based on the crystallographic studies of IAPP fragments that shares many features with the solid state NMR model described above but differs in how the two columns of IAPP monomers pack against each other and in the length of the C-terminal <italic>&#946;</italic>-strand [<xref rid="B49" ref-type="bibr">49</xref>]. Thirdly, EPR studies of IAPP variants lacking the Cys<sup>2</sup>&#8211;Cys<sup>7</sup> disulfide bond have led to a slight variation of these two models. The protofibrils are still built up of U-shaped stacks of monomers, but the planes of the two <italic>&#946;</italic>-strands within one IAPP molecule are staggered by around 15&#8201;&#197; [<xref rid="B50" ref-type="bibr">50</xref>]. Interestingly, in these three models, the 20&#8211;29 amyloidogenic segment is not part of a <italic>&#946;</italic>-sheet. Instead, it forms a partially ordered bend that connects the two <italic>&#946;</italic>-strands, questioning the sensitivity of hIAPP amyloid formation to substitutions and/or modifications within this amyloidogenic prone region [<xref rid="B51" ref-type="bibr">51</xref>]. Structural analysis of IAPP fibrils was so far exclusively performed using homogenous peptide assemblies, although amyloid deposits in islets of Langerhans of diabetic patients contain a variety of biomolecules, including GAGs, lipids, and other proteins. Thus, it will be interesting to study the molecular architecture of IAPP amyloids assembled in a biologically relevant heterogeneous environment.</p></sec><sec id="sec3.2"><title>3.2. Models of IAPP Amyloid Formation</title><p>While the mechanism by which proteins self-assemble into amyloids has been intensively studied over the last two decades, mechanistic details remain partially elusive and still the matter of controversy. Amyloidogenic polypeptides can be divided into two different structural classes: those that are intrinsically (or partially) disordered in their native state and those that show a well-defined tertiary structure in their monomeric soluble state. Generally, natively folded amyloidogenic proteins, such as transthyretin and <italic>&#946;</italic>2-microglobulin, have to unfold (or misfold), at least partially, to form amyloids. In contrast, intrinsically disordered polypeptides, such as IAPP and A<italic>&#946;</italic> peptide, need to undergo conformational rearrangements allowing the formation of locally ordered structure(s) to initiate the amyloidogenic process. The formation of amyloid fibrils is often described as a nucleation-dependent polymerization, although other models have been suggested [<xref rid="B52" ref-type="bibr">52</xref>], including the nucleated conformational conversion [<xref rid="B53" ref-type="bibr">53</xref>] and the monomer-directed conversion [<xref rid="B54" ref-type="bibr">54</xref>]. The nucleated polymerization model is characterized by the rate-limiting formation of the nucleus, which results from the equilibrium between monomers that are and are not assembly competent [<xref rid="B52" ref-type="bibr">52</xref>]. As soon as the nucleus is formed, assembly rapidly occurs by the addition of competent monomers to the growing end of the protofibrils. This model is characterized by two well-defined kinetics phases. Firstly, a low amount of dynamic and transient oligomeric species is produced in the lag phase. This phase takes place slowly because of the unfavorable interactions between monomers to form oligomers. Secondly, once the nucleus (competent oligomer) is formed, the elongation phase begins, leading to the rapid growth of the (bio)polymers [<xref rid="B55" ref-type="bibr">55</xref>]. Amyloid formation kinetics, seeding experiments as well as the difficulty of detecting low ordered oligomers [<xref rid="B23" ref-type="bibr">23</xref>], suggest that IAPP amyloidogenesis could be ascribed to a nucleated polymerization.</p><p>Recent studies performed with different amyloidogenic proteins have suggested that oligomers could be the most proteotoxic species of the aggregation cascade [<xref rid="B56" ref-type="bibr">56</xref>&#8211;<xref rid="B58" ref-type="bibr">58</xref>]. This hypothesis has prompted the biophysical investigation of the early steps in protein aggregation. For IAPP, two major models have been proposed for its oligomerization in homogenous solution: the helical intermediates model [<xref rid="B59" ref-type="bibr">59</xref>] and the <italic>&#946;</italic>-hairpins model [<xref rid="B60" ref-type="bibr">60</xref>]. As inferred from NMR analysis and<italic> in silico</italic> prediction, monomeric soluble IAPP transiently adopts an <italic>&#945;</italic>-helix between residues 5&#8211;19 [<xref rid="B28" ref-type="bibr">28</xref>] and it has been suggested that this helical intermediate could be on-pathway to amyloid formation. For instance, by analyzing the kinetics of <italic>&#946;</italic>-sheet formation using two-dimensional infrared (2D IR) spectroscopy, it was observed that the disappearance of the random coil conformation was associated with the emergence of a <italic>&#945;</italic>-helix [<xref rid="B61" ref-type="bibr">61</xref>]. Besides, the presence of a low percentage of HFIP, a solvent known to promote helical formation, in the aggregation solution of IAPP accelerates the rate of amyloid formation [<xref rid="B62" ref-type="bibr">62</xref>, <xref rid="B63" ref-type="bibr">63</xref>]. Similarly, whereas the binding of IAPP to model membranes favors its initial conformational conversion from a random coil to a <italic>&#945;</italic>-helix, it is well known that lipid vesicles significantly accelerate IAPP amyloid formation [<xref rid="B64" ref-type="bibr">64</xref>]. According to the helical intermediates hypothesis, self-association would be thermodynamically associated with helix formation within the 5&#8211;20 segment, in a similar way of the driven forces of coiled-coil motif formation [<xref rid="B59" ref-type="bibr">59</xref>]. In turn, this transient helical oligomer would generate a high local concentration of the C-terminal amyloidogenic segment of IAPP, favoring the intermolecular <italic>&#946;</italic>-sheets formation. This <italic>&#946;</italic>-sheet structure would then propagate leading to the formation of <italic>&#946;</italic>-sheet rich supraassemblies [<xref rid="B59" ref-type="bibr">59</xref>]. Taking into account this model, several molecules have been recently designed to target and stabilize helical intermediates with the ultimate goal of inhibiting IAPP amyloid formation [<xref rid="B65" ref-type="bibr">65</xref>&#8211;<xref rid="B68" ref-type="bibr">68</xref>]. By combining ion mobility mass spectrometry and molecular dynamics simulations, it was instead proposed that IAPP early oligomerization steps include the formation of <italic>&#946;</italic>-strand rich dimers [<xref rid="B29" ref-type="bibr">29</xref>, <xref rid="B60" ref-type="bibr">60</xref>]. Bowers and colleagues have suggested that IAPP <italic>&#946;</italic>-sheet-rich assemblies are formed from ordered beta-hairpins rather than from coiled structures. The discrepancy between these two models indicates that the initial events of IAPP amyloidogenesis still remain unclear. It is worth mentioning that in contrast to<italic> in vitro</italic> homogenous aqueous solution, the mechanisms of amyloid formation<italic> in vivo</italic> are most likely to be different and could involve alternative pathways. IAPP amyloidogenesis takes place in a heterogeneous and crowded environment with the potential interactions with several components of the extracellular matrix and the plasma membrane. Thus, mechanistic examinations of amyloid formation in heterogeneous environments constitute an important issue and relevant studies will now be discussed.</p></sec></sec><sec id="sec4"><title>4. Biochemical Factors Modulating IAPP Amyloidogenesis</title><p>Amyloid formation has been originally perceived as a self-assembly homogeneous process in which the inherent physicochemical and structural properties of the amyloidogenic proteic precursor as well as its concentration constitute the major driving forces to fibrillation. Accordingly, the presence of biomolecules tightly associated with the amyloids<italic> in vivo</italic>, including GAGs, metals, glycoproteins, and lipids, was seen as a contamination of the fibrils occurring after aggregation and/or deposition. However, numerous biophysical investigations as well as<italic> in vivo</italic> biochemical studies have shown a prominent role of these extrinsic factors in amyloid deposition associated with the etiology of various diseases, including type II diabetes [<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B8" ref-type="bibr">8</xref>, <xref rid="B9" ref-type="bibr">9</xref>]. It is now evident that the biochemical microenvironment in which amyloid formation occurs and the interactions of the polypeptide precursor with various biomolecules not only modulate the rate and extent of aggregation, but also remodel the mechanisms as well as the structure, toxicity and stability of the resulting fibrils.</p><sec id="sec4.1"><title>4.1. Glycosaminoglycans</title><p>Immunohistochemical analysis revealed that the basement membrane heparan sulfate proteoglycan (HSPG), perlecan, was present within islet amyloid deposits, suggesting a causative role of sulfated GAGs in IAPP fibrillogenesis [<xref rid="B69" ref-type="bibr">69</xref>]. Besides, incubation of hIAPP transgenic mouse isolated islets with WAS-406, an inhibitor of HSPGs synthesis, resulted in a dose-dependent decrease in amyloid formation [<xref rid="B70" ref-type="bibr">70</xref>]. Similarly, the Westermark group has established a mouse strain that overexpresses both hIAPP and heparanase, an enzyme that catalyzes the cleavage of cell surface heparan sulfate. They reported that isolated islets from these mice showed a marked reduction in amyloid accumulation upon a 2-week high glucose treatment; these conditions simulate the hyperglycemia observed in type II diabetes and stimulate IAPP expression and secretion [<xref rid="B71" ref-type="bibr">71</xref>]. In addition, since the original work by Castillo et al. [<xref rid="B72" ref-type="bibr">72</xref>], several reports have shown that sulfated GAGs, including heparin, heparan sulfate, and heparin derivatives, accelerate dramatically the rate of IAPP and pro-IAPP amyloid formation<italic> in vitro</italic> [<xref rid="B73" ref-type="bibr">73</xref>&#8211;<xref rid="B77" ref-type="bibr">77</xref>]. Overall, these studies constitute a clear testimony that sulfated GAGs could play an active role in islet amyloid deposition associated with type II diabetes.</p><p>GAGs are long and linear polysaccharides composed of repeating disaccharide units and some GAGs can contain up to 200 repeating disaccharide units [<xref rid="B78" ref-type="bibr">78</xref>]. They are abundant on the outer leaflet of the plasma membrane of every cell type of metazoan organisms and in their basement membrane and extracellular matrix (ECM) [<xref rid="B79" ref-type="bibr">79</xref>]. According to the structure of their carbohydrate backbone, GAGs can be classified into several classes. The most ubiquitous class of GAG is heparan sulfate (<xref ref-type="fig" rid="fig3">Figure 3(a)</xref>) which is expressed at the cell surface of nearly every cells, constituting more than 50% of total proteoglycans [<xref rid="B80" ref-type="bibr">80</xref>, <xref rid="B81" ref-type="bibr">81</xref>]. Other types of GAGs include heparin, chondroitin sulfate, dermatan sulfate, keratan sulfate, and hyaluronic acid. Owing to their high density of carboxylate and sulfate groups, GAGs are highly negatively charged biopolymers that constitute a major reservoir of polyanions surrounding cells. With exception of hyaluronic acid and heparin, GAGs are usually covalently O-linked to a protein core, forming a structure known as proteoglycans. HSPGs, which constitute approximately 95% of all proteoglycans [<xref rid="B82" ref-type="bibr">82</xref>], are present in all tissues and comprise five types of protein core, including the cell surface syndecan and the ECM perlecan, the latter being a major constituent of pancreatic islet amyloids [<xref rid="B69" ref-type="bibr">69</xref>].</p><p>Over the last 15 years, several studies have demonstrated that the addition of sulfated GAGs to amyloidogenic proteins accelerates their fibrillogenesis<italic> in vitro</italic>. These polypeptides include both intrinsically disordered polypeptides such as the A<italic>&#946;</italic> peptide [<xref rid="B83" ref-type="bibr">83</xref>], <italic>&#945;</italic>-synuclein [<xref rid="B84" ref-type="bibr">84</xref>], and IAPP [<xref rid="B72" ref-type="bibr">72</xref>] and natively folded proteins such as transthyretin [<xref rid="B85" ref-type="bibr">85</xref>], gelsolin [<xref rid="B86" ref-type="bibr">86</xref>], and <italic>&#946;</italic>2-microglobulin [<xref rid="B87" ref-type="bibr">87</xref>]. It has been proposed that GAGs hasten amyloidogenesis by a scaffold-based mechanism, in which the amyloidogenic protein, either in its monomeric or oligomeric form, interacts with the sulfated polysaccharides mainly through electrostatic interactions, increasing its local concentration and promoting aggregation [<xref rid="B85" ref-type="bibr">85</xref>, <xref rid="B86" ref-type="bibr">86</xref>, <xref rid="B88" ref-type="bibr">88</xref>]. It was also reported that the interaction with GAGs induces the conformational transition of the 3&#8201;kDa fragment of gelsolin [<xref rid="B89" ref-type="bibr">89</xref>] and A<italic>&#946;</italic> peptide [<xref rid="B83" ref-type="bibr">83</xref>] from a random coil to <italic>&#946;</italic>-sheet. However, this structural modification is most likely related to the aggregation process rather than to a conformational conversion within the monomeric protein.</p><p>The mechanisms by which sulfated GAGs accelerate IAPP amyloid formation have been studied by a combination of biophysical approaches and are similar to the one described for other amyloidogenic polypeptides. Owing to its net positive charge at physiological pH, IAPP can bind by means of electrostatic interactions with polyanionic sulfated GAGs. As a matter of fact, it was observed by NMR spectroscopy that heparin binds to the N-terminal segment of IAPP [<xref rid="B73" ref-type="bibr">73</xref>], which includes the only four potential positive charges in IAPP sequence: the <italic>&#945;</italic>-amino group, Lys-1, Arg-11, and His-18. Besides, it was reported by isothermal titration calorimetry (ITC) that the affinity of IAPP to sulfated GAGs was dependent on the protonation state of His-18 and that the binding was predominately enthalpy-driven, most related to electrostatic interactions [<xref rid="B75" ref-type="bibr">75</xref>]. A heparin binding site was characterized within the N-terminal domain of proIAPP [<xref rid="B77" ref-type="bibr">77</xref>, <xref rid="B90" ref-type="bibr">90</xref>] and it was suggested that the interaction of unprocessed proIAPP with sulfated GAGs could have strong implications for amyloid formation in pancreatic islets. FRET analyses between ThT and fluorescein-labelled heparin (FH) [<xref rid="B73" ref-type="bibr">73</xref>, <xref rid="B74" ref-type="bibr">74</xref>] showed that IAPP binds to sulfated GAGs before amyloid formation, most likely in its monomeric form. As reported for other amyloidogenic polypeptides, heparin is incorporated into the fibrils and/or is tightly associated with the mature amyloids. By CD spectroscopy, IAPP and proIAPP association to sulfated GAGs induces a random coil to <italic>&#945;</italic>-helix conformational conversion [<xref rid="B75" ref-type="bibr">75</xref>, <xref rid="B77" ref-type="bibr">77</xref>] and this helical structure is rapidly converted into a <italic>&#946;</italic>-sheet structure. As the binding of IAPP and proIAPP accelerates the rate of amyloid formation, this secondary conformational conversion supports the helical intermediates hypothesis described above. By using heparin analogs of different length and/or degree of sulfation, it was reported that the effects of GAGs on IAPP amyloidogenesis were dependent on the oligosaccharide length and sulfate content and not on the amount of charged monomers [<xref rid="B72" ref-type="bibr">72</xref>, <xref rid="B73" ref-type="bibr">73</xref>]. Nonetheless, it was observed that the degree of sulfation of heparan sulfate isolated from pancreatic <italic>&#946;</italic>-TC3 cells does not determine all aspects of GAG-mediated amyloid formation [<xref rid="B91" ref-type="bibr">91</xref>]. Besides, the nature of GAG backbone also affects, to some extent, the enhancement of IAPP fibril formation [<xref rid="B72" ref-type="bibr">72</xref>, <xref rid="B92" ref-type="bibr">92</xref>]. Overall, these studies suggest a model for GAGs-accelerated IAPP amyloidogenesis in which the positively charged N-terminal segment of the peptide binds to the sulfate moieties of GAGs, inducing the formation of a <italic>&#945;</italic>-helix. In turn, this generates a high local concentration of peptide on GAG scaffold that drives the association of IAPP amyloidogenic segment, accelerating drastically the formation of <italic>&#946;</italic>-sheet rich assemblies (<xref ref-type="fig" rid="fig3">Figure 3(b)</xref>).</p></sec><sec id="sec4.2"><title>4.2. Metals</title><p>Several reports have suggested that the dysregulation of metal ion homeostasis could be implicated in the pathogenesis of amyloid diseases, comprising type II diabetes [<xref rid="B9" ref-type="bibr">9</xref>]. Binding sites for transition metals, including zinc, copper, and iron, have been characterized in numerous amyloidogenic polypeptides, such as A<italic>&#946;</italic> peptide [<xref rid="B93" ref-type="bibr">93</xref>], <italic>&#945;</italic>-synuclein [<xref rid="B94" ref-type="bibr">94</xref>], and <italic>&#946;</italic>2-microglobulin [<xref rid="B95" ref-type="bibr">95</xref>]. Most of mechanistic studies have been so far performed with the A<italic>&#946;</italic> peptides and have shown that physiological concentrations of metals, particularly Zn<sup>2+</sup>, are sufficient to accelerate the rate of amyloid formation, although divergent results were reported [<xref rid="B96" ref-type="bibr">96</xref>]. While it is known for more than 20 years that the secretory granules in pancreatic islets of Langerhans, which store IAPP and insulin, are characterized by a high concentration of zinc [<xref rid="B97" ref-type="bibr">97</xref>], the role of this metal in IAPP amyloidogenesis has not been addressed until recently [<xref rid="B98" ref-type="bibr">98</xref>, <xref rid="B99" ref-type="bibr">99</xref>]. Particularly, it has been reported that zinc transport into <italic>&#946;</italic>-cells secretory granules, involving the pancreas-restricted zinc transporter ZnT8, could play a significant role in the etiology of type II diabetes [<xref rid="B100" ref-type="bibr">100</xref>, <xref rid="B101" ref-type="bibr">101</xref>]. This observation suggests that zinc homeostasis could be associated with IAPP misfolding/aggregation, although this avenue has not been explored<italic> in vivo</italic> so far.</p><p>The modulation of IAPP amyloidogenesis<italic> in vitro</italic> by zinc is complex and is dependent on zinc concentration as well as the pH and peptide concentration [<xref rid="B98" ref-type="bibr">98</xref>]. At pH 7.5, the presence of a low concentration of Zn<sup>2+</sup> in the incubation solution decreases the rate of amyloid formation whereas at higher concentration the fibril elongation rate increases. It was also observed that while the total amount of fibrils is greatly reduced by zinc at all concentrations, the general morphology of the individual fibrils remained somewhat similar [<xref rid="B98" ref-type="bibr">98</xref>]. Notably, typical concentrations of zinc reported in the extracellular space where IAPP deposition occurs, ranging from 10 to 25&#8201;<italic>&#956;</italic>M [<xref rid="B102" ref-type="bibr">102</xref>], decrease significantly amyloid formation at physiological pH. In sharp contrast, at pH 5.5, at which the residue His-18 is protonated, zinc accelerated IAPP fibrillogenesis. Brender and colleagues have observed that IAPP in an organic solvent undergoes a structural conversion upon zinc binding characterized by a local disruption of the helical structure around residue His-18 [<xref rid="B98" ref-type="bibr">98</xref>]. Thus, the inhibitory effect of zinc observed at low concentrations was initially ascribed to the unfavorable incorporation of a charge inside the loops [<xref rid="B98" ref-type="bibr">98</xref>], as the imidazole ring of His-18 is located in the hydrophobic core of the fiber [<xref rid="B48" ref-type="bibr">48</xref>]. By combining ITC, NMR, and ESI mass spectrometry, it was observed that zinc favors the formation of off-pathway hexameric species while creating an energetic barrier for the formation of amyloids [<xref rid="B103" ref-type="bibr">103</xref>]. Thus, zinc binding to nonfibrillar IAPP with an affinity in the micromolar range [<xref rid="B103" ref-type="bibr">103</xref>] promotes the formation of prefibrillar aggregates [<xref rid="B99" ref-type="bibr">99</xref>], ultimately inhibiting the formation of amyloid fibrils.</p><p>The inhibition of amyloid formation by metals appears to be restricted to metals that are known as good ligands for histidine, such as Zn<sup>2+</sup> and Cu<sup>2+</sup>, whereas Mg<sup>2+</sup> and Ca<sup>2+</sup>, which are poor imidazole ligands, have no significant effect on IAPP amyloidogenesis [<xref rid="B98" ref-type="bibr">98</xref>, <xref rid="B104" ref-type="bibr">104</xref>]. The effect of the buffer ion composition on the kinetics of IAPP amyloid formation was recently examined and it was reported that IAPP fibrillogenesis was dependent on the anion identity, while the nature of the cationic species has little effect on the rate of fibrils formation [<xref rid="B105" ref-type="bibr">105</xref>]. Overall, whereas the modulation of <italic>&#945;</italic>-synuclein and A<italic>&#946;</italic>-peptide amyloidogenesis by metals is well-documented, the role of metal homeostasis in islet IAPP deposition has been so far less studied and deserves further attention. Particularly, it will be interesting to probe the effects of zinc and copper on the kinetics of IAPP self-assembly in heterogeneous environment, that is, in presence of other biological factors such as GAGs and lipid membrane models.</p></sec><sec id="sec4.3"><title>4.3. Other Factors Modulating IAPP Amyloidogenesis</title><p>Virtually all amyloid deposits, including islet amyloids [<xref rid="B106" ref-type="bibr">106</xref>, <xref rid="B107" ref-type="bibr">107</xref>], are associated with apolipoprotein E (apoE), a protein involved in lipid transport and metabolism. The importance of this protein in amyloid deposition has been highlighted in Alzheimer's disease as transgenic mice lacking the ApoE gene form only diffuse plaques but not mature neuritic plaques [<xref rid="B108" ref-type="bibr">108</xref>]. In sharp contrast, transgenic mice expressing hIAPP crossbred with apoE deficient mice showed similar prevalence and severity of islet amyloids, indicating that apoE is not a critical factor for islet amyloid deposition [<xref rid="B109" ref-type="bibr">109</xref>]. Nonetheless, it was observed<italic> in vitro</italic> that ApoE4 binds IAPP and inhibits amyloid formation [<xref rid="B110" ref-type="bibr">110</xref>]. Insulin, which is stored with IAPP in <italic>&#946;</italic>-cell secretory granules, is one of the most potent inhibitors of IAPP aggregation [<xref rid="B111" ref-type="bibr">111</xref>]. Insulin binds to the putative helical domain of IAPP, stabilizing the compact isoform of IAPP and inhibiting the formation of <italic>&#946;</italic>-sheets [<xref rid="B112" ref-type="bibr">112</xref>, <xref rid="B113" ref-type="bibr">113</xref>]. The postulated mechanism of fibrillogenesis inhibition by insulin is consistent with the helical intermediates hypothesis. Anionic model membranes are the most studied biological cofactors in the context of IAPP amyloidogenesis, since they not only accelerate IAPP amyloid formation but they also recapitulate the postulated initial site of IAPP-induced cell death. The mechanisms of lipid-accelerated IAPP amyloidogenesis have been previously addressed in several excellent reviews [<xref rid="B20" ref-type="bibr">20</xref>&#8211;<xref rid="B23" ref-type="bibr">23</xref>, <xref rid="B114" ref-type="bibr">114</xref>] and readers are invited to consult them for additional information.</p></sec></sec><sec id="sec5"><title>5. Mechanism of IAPP Cytotoxicity</title><sec id="sec5.1"><title>5.1. The Toxic Oligomeric Species Hypothesis</title><p>The presence of insoluble protein deposition in the pancreatic islets of patients suffering from type II diabetes has initially led to the postulate that amyloid fibrils cause <italic>&#946;</italic>-cell degeneration [<xref rid="B115" ref-type="bibr">115</xref>]. This hypothesis was later reinforced by the work of Lorenzo and colleagues demonstrating the potential toxicity of IAPP fibrils on human pancreatic islet cells [<xref rid="B116" ref-type="bibr">116</xref>]. This cell death event was associated with membrane blebbing, chromatin condensation, and DNA fragmentation, indicating that IAPP amyloids trigger <italic>&#946;</italic>-cell apoptosis. However, over the last fifteen years, several studies have instead suggested that nonfibrillar intermediates are the most toxic species of IAPP amyloid cascade. For instance, it was observed that the inhibition of amyloid fibril formation with rifampicin did not reduce IAPP-induced pancreatic cell death [<xref rid="B117" ref-type="bibr">117</xref>]. Furthermore, in a homozygous hIAPP transgenic mouse model, selective <italic>&#946;</italic>-cell death and impaired insulin secretion were associated with the formation of early, small amorphous intra- and extracellular aggregates rather than with large amyloid deposits [<xref rid="B118" ref-type="bibr">118</xref>]. Bram and colleagues have recently reported the isolation of antibodies from diabetic patients that specifically recognized IAPP oligomers. Remarkably, these antibodies were shown to neutralize the apoptotic effect induced by IAPP cytotoxic species on <italic>&#946;</italic>-cell [<xref rid="B119" ref-type="bibr">119</xref>]. Moreover, dynamic light scattering revealed that cytotoxicity corresponds to IAPP aggregates containing between 25 and 6&#8201;000 IAPP molecules [<xref rid="B120" ref-type="bibr">120</xref>]. Thus, as for other amyloid-related diseases, the scientific community generally agrees on the hypothesis that prefibrillar aggregates might be the toxic species causing <italic>&#946;</italic>-cell death. However, considering that pancreatic islets from patients afflicted with type II diabetes are almost all converted into amyloids, this massive IAPP deposition most likely interferes with normal <italic>&#946;</italic>-cell functions, such as insulin release [<xref rid="B19" ref-type="bibr">19</xref>]. Noteworthy, the search for the culprit species of the amyloidogenic cascade has been so far exclusively performed with aggregates prepared in IAPP homogenous solution. However, as described above, amyloid cofactors such as metals, GAGs, and lipids can remodel the pathway of aggregation and can lead to the formation of oligomer species with unusual morphological, physicochemical, and/or biological properties. Thus, it will be crucial in the nearest future to characterize the cytotoxicity of IAPP oligomers prepared in heterogeneous environment that reconstitutes, as possible, the extracellular environment of pancreatic islets.</p></sec><sec id="sec5.2"><title>5.2. Mechanisms of IAPP-Induced Cytotoxicity</title><p>Although the mechanisms by which IAPP induced <italic>&#946;</italic>-cell death have been intensively investigated since IAPP discovery, the subject is very complex and is still the matter of debate. This topic has been recently discussed in excellent reviews [<xref rid="B23" ref-type="bibr">23</xref>, <xref rid="B121" ref-type="bibr">121</xref>, <xref rid="B122" ref-type="bibr">122</xref>] and, accordingly, we will briefly present the main postulated mechanisms. One of the most studied and accepted mechanisms is membrane disruption and transmembrane pore formation [<xref rid="B20" ref-type="bibr">20</xref>]. IAPP is a cationic peptide, favoring its electrostatic interaction with anionic lipids of the plasma membrane. Indeed, the nature of membrane model composition influences its aggregation [<xref rid="B123" ref-type="bibr">123</xref>]. Experiments performed with planar phospholipid bilayer membranes showed the formation of nonselective ion-permeable channels, suggesting that channel-like formation could trigger IAPP-induced cell death [<xref rid="B124" ref-type="bibr">124</xref>]. Similarly, the formation of abnormal vesicle-like membrane structures was observed when freshly dissolved IAPP was added to mouse and human islet cells [<xref rid="B120" ref-type="bibr">120</xref>]. Apoptosis, or programmed cell death, is another mechanism by which IAPP can cause <italic>&#946;</italic>-cell death and is closely associated with membrane disruption. Actually, nonspecific channel-like formation by IAPP causes a high influx of Ca<sup>2+</sup> inside the cell that can engage apoptosis [<xref rid="B125" ref-type="bibr">125</xref>, <xref rid="B126" ref-type="bibr">126</xref>]. DNA fragmentation, a key apoptosis characteristic, was observable for RINm5F cells exposed to IAPP [<xref rid="B127" ref-type="bibr">127</xref>]. Moreover, IAPP induces p53 activation, a well-known tumor suppressing gene that regulates the cycle and increases the transcription of proapoptotic factors [<xref rid="B128" ref-type="bibr">128</xref>]. Similarly, it was observed that the gene encoding the G1 inhibitor p21 is upregulated when cells are incubated in presence of IAPP aggregates [<xref rid="B127" ref-type="bibr">127</xref>]. These studies suggest that IAPP can also trigger nonspecific apoptotic pathways. Besides, IAPP expression in islets upregulates the expression of the FAS receptor, a transmembrane protein able to engage programmed cell death, whereas the deletion of FAS reduced IAPP-induced toxicity [<xref rid="B129" ref-type="bibr">129</xref>], suggesting the involvement of specific apoptotic pathways.</p><p>Several studies have indicated that IAPP can induce pancreatic cell death by inducing the generation of reactive oxygen species (ROS). For instance, an increased level of ROS was observed when cells were exposed to IAPP oligomers [<xref rid="B130" ref-type="bibr">130</xref>]. Interestingly, it was observed that phycocyanin, a natural compound known for its antioxidant properties, protects pancreatic <italic>&#946;</italic>-cells against IAPP-induced apoptosis by attenuating oxidative stress and modulating apoptotic pathways [<xref rid="B130" ref-type="bibr">130</xref>]. In contrast, treatment with the antioxidant N-acetyl-L-cysteine (NAC) prevented the rise of ROS induced by IAPP but did not prevent <italic>&#946;</italic>-cell apoptosis [<xref rid="B131" ref-type="bibr">131</xref>]. Due to peripheral insulin resistance associated with type II diabetes, insulin and IAPP expression, maturation, and secretion by pancreatic <italic>&#946;</italic>-cells are significantly increased [<xref rid="B132" ref-type="bibr">132</xref>]. This can overload the endoplasmic reticulum (ER), leading to ER stress and the activation of the unfolded protein response (UPR). For instance, an elevated expression of IAPP in hIAPP transgenic rats induces ER-stress, ultimately leading to <italic>&#946;</italic>-cells apoptosis [<xref rid="B133" ref-type="bibr">133</xref>]. Interestingly, by establishing a mouse model overexpressing rIAPP at a comparable rate as the transgenic hIAPP mouse model, it was reported that the elevated ER stress depends on the propensity of IAPP to aggregate but is not the consequence of protein overexpression [<xref rid="B134" ref-type="bibr">134</xref>]. It was recently showed that the expression of hIAPP in mice with a <italic>&#946;</italic> cell-specific autophagy defect results in an increase of <italic>&#946;</italic>-cell dysfunction associated with IAPP-toxicity [<xref rid="B135" ref-type="bibr">135</xref>], suggesting a protective role of autophagy in type II diabetes. Overall, these studies indicate that IAPP-mediated cytotoxicity is multifaceted and is triggered by multiple mechanisms that are intrinsically related to each other.</p></sec><sec id="sec5.3"><title>5.3. Roles of Amyloid Cofactors in IAPP-Induced Cytotoxicity</title><p>Whereas biophysical studies have indicated that amyloid cofactors, including GAGs, metals, and lipids, can remodel IAPP aggregation landscape and biochemical investigations have suggested that oligomeric species induce <italic>&#946;</italic>-cell death, it appears crucial to address the roles of these cofactors in IAPP-induced toxicity. It was observed that the coinjection of sulfated GAGs with IAPP in the culture media protects <italic>&#946;</italic>-pancreatic cells against IAPP-mediated cytotoxicity [<xref rid="B73" ref-type="bibr">73</xref>, <xref rid="B75" ref-type="bibr">75</xref>]. This result suggests that, by hastening amyloid formation, sulfated GAGs stimulate the formation of nontoxic fibrillar species, in agreement with the toxic oligomeric species hypothesis. The role of cell surface proteoglycans in IAPP-mediated cell death has been recently investigated. INS-1 cells treated with heparinase and chondroitinase in order to cleave polysaccharide chains of proteoglycans showed a similar vulnerability to IAPP to their nontreated counterpart [<xref rid="B75" ref-type="bibr">75</xref>]. This data indicates that the lack of GAGs on the outer leaflet of the plasma membrane does not prevent nor increases IAPP toxicity. This result was confirmed by means of the mutant CHO cell pgsA-745 [<xref rid="B75" ref-type="bibr">75</xref>], which lacks cell surface GAGs as a result of a deficiency in xylosyltransferase, a key enzyme in proteoglycans biosynthesis [<xref rid="B136" ref-type="bibr">136</xref>]. These observations are not in line with previous studies performed with the A<italic>&#946;</italic> peptide showing that heparan sulfate deficient cells were essentially resistant to A<italic>&#946;</italic> cytotoxicity [<xref rid="B137" ref-type="bibr">137</xref>]. Similarly, A<italic>&#946;</italic> toxicity is attenuated in embryonic kidney cells overexpressing heparinase [<xref rid="B137" ref-type="bibr">137</xref>]. Nonetheless, as reported for IAPP, the removal of cell surface GAGs did not prevent HypF-N aggregates toxicity [<xref rid="B138" ref-type="bibr">138</xref>], suggesting some heterogeneity among the mechanisms of cell death induced by amyloidogenic polypeptides.</p><p>As described above, membrane disruption, including pore formation and membrane fragmentation, appears to play a key mechanistic role in the toxicity induced by IAPP on <italic>&#946;</italic>-pancreatic cells. However, the contribution of the plasma membrane lipid composition and of its physicochemical properties on the cellular susceptibility towards IAPP has not been directly addressed so far. In an elegant work, Evangelisti and co-workers have recently shown that the extent of cytotoxicity of HypF-N oligomers is the result of a complex interplay between the physicochemical features of both the cell membrane and the oligomeric species [<xref rid="B139" ref-type="bibr">139</xref>]. Regarding IAPP, it was reported that depletion of cholesterol from plasma membrane of rat insulinoma cells inhibits the internalization of oligomers, which in turn potentiates IAPP cytotoxicity [<xref rid="B140" ref-type="bibr">140</xref>]. By means of real-time single particle tracking, it was shown that IAPP aggregates interact with GM1 gangliosides and decrease their lateral diffusion in neuroblastoma cell membrane [<xref rid="B141" ref-type="bibr">141</xref>]. As GM1 is a major constituent of membrane lipid rafts, which are known for their contribution to cell signaling pathways, it will be interesting to probe the role of GM1 in IAPP-induced toxicity. By combining biophysical approaches, it was shown that phosphatidylethanolamine (PE) phospholipids modulate the<italic> in vitro</italic> membrane disruption induced by IAPP [<xref rid="B142" ref-type="bibr">142</xref>]. This result suggests a possible role of PE in IAPP plasma membrane disruption, although this possibility has not been addressed<italic> in vivo</italic> so far. It was recently observed that copper interacts with IAPP to form metallopeptide complexes showing low toxicity towards pancreatic rat <italic>&#946;</italic>-cells [<xref rid="B143" ref-type="bibr">143</xref>], indicating that metal ions can also modulate IAPP-induced cell death.</p></sec></sec><sec id="sec6"><title>6. Conclusion</title><p>As summarized in this review, the role of the<italic> so-called</italic> accessory amyloid biomolecules in IAPP amyloidogenesis has been recently investigated by a combination of biophysical approaches. Regardless of the complexity of the microenvironment in which IAPP deposition occurs, the effects of several biological cofactors on amyloid formation are being increasingly recognized. Nonetheless, several issues should be addressed in order to better appreciate the implication of these biomolecules in the development of amyloid deposition. In turn, this knowledge should lead to deeper understanding of the mechanisms by which IAPP induced <italic>&#946;</italic>-cell degeneration. Taking into account the prominent role of GAGs, metals, and lipids in IAPP amyloidogenesis, it will be particularly important that the identification of amyloid inhibitors<italic> in vitro</italic> is performed in milieu that recapitulates, as much as possible, the complex biological environment in which IAPP aggregation occurs. For instance, Hebda and colleagues have recently performed the screening of small molecules in presence of lipid membrane model and identified 36 molecules that were not previously reported as active toward IAPP fibril formation in homogenous solution [<xref rid="B144" ref-type="bibr">144</xref>]. Similarly, it was observed that the capacity of insulin to inhibit IAPP amyloidogenesis is significantly reduced in presence of sulfated GAGs [<xref rid="B145" ref-type="bibr">145</xref>] whereas the inhibition of IAPP fibrillogenesis by IS5, a small molecule alpha helix mimetic, is increased in presence of heparin [<xref rid="B146" ref-type="bibr">146</xref>]. Considering that the simplistic model of IAPP fibrillogenesis as a homogenous self-assembly process does not recapitulate amyloid deposition associated with the etiology of type II diabetes, it will be important in the future to develop<italic> in vitro</italic> experimental conditions to study IAPP aggregation that resemble the complexity of the pancreatic islet environment.</p></sec></body><back><ack><title>Acknowledgments</title><p>The authors apologize to all research groups whose contributions could not be cited due to space limitations. This work was supported by grants from the Natural Sciences and Engineering Research Council of Canada (NSERC) and the Fonds de Recherche du Qu&#233;bec-Nature et technologies (FRQNT).</p></ack><sec sec-type="conflict"><title>Conflict of Interests</title><p>The authors declare that there is no conflict of interests regarding the publication of this paper.</p></sec><ref-list><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiti</surname><given-names>F.</given-names></name><name><surname>Dobson</surname><given-names>C. M.</given-names></name></person-group><article-title>Protein misfolding, functional amyloid, and human disease</article-title><source><italic>Annual Review of Biochemistry</italic></source><year>2006</year><volume>75</volume><fpage>333</fpage><lpage>366</lpage><pub-id pub-id-type="doi">10.1146/annurev.biochem.75.101304.123901</pub-id><pub-id pub-id-type="other">2-s2.0-33746377894</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kelly</surname><given-names>J. W.</given-names></name></person-group><article-title>The alternative conformations of amyloidogenic proteins and their multi-step assembly pathways</article-title><source><italic>Current Opinion in Structural Biology</italic></source><year>1998</year><volume>8</volume><issue>1</issue><fpage>101</fpage><lpage>106</lpage><pub-id pub-id-type="doi">10.1016/S0959-440X(98)80016-X</pub-id><pub-id pub-id-type="other">2-s2.0-0032006678</pub-id><pub-id pub-id-type="pmid">9519302</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sekijima</surname><given-names>Y.</given-names></name><name><surname>Wiseman</surname><given-names>R. L.</given-names></name><name><surname>Matteson</surname><given-names>J.</given-names></name><etal/></person-group><article-title>The biological and chemical basis for tissue-selective amyloid disease</article-title><source><italic>Cell</italic></source><year>2005</year><volume>121</volume><issue>1</issue><fpage>73</fpage><lpage>85</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2005.01.018</pub-id><pub-id pub-id-type="other">2-s2.0-17044402604</pub-id><pub-id pub-id-type="pmid">15820680</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coelho</surname><given-names>T.</given-names></name><name><surname>Maia</surname><given-names>L. F.</given-names></name><name><surname>Da Silva</surname><given-names>A. M.</given-names></name><etal/></person-group><article-title>Tafamidis for transthyretin familial amyloid polyneuropathy: a randomized, controlled trial</article-title><source><italic>Neurology</italic></source><year>2012</year><volume>79</volume><issue>8</issue><fpage>785</fpage><lpage>792</lpage><pub-id pub-id-type="doi">10.1212/wnl.0b013e3182661eb1</pub-id><pub-id pub-id-type="other">2-s2.0-84862222705</pub-id><pub-id pub-id-type="pmid">22843282</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cohen</surname><given-names>F. E.</given-names></name><name><surname>Kelly</surname><given-names>J. W.</given-names></name></person-group><article-title>Therapeutic approaches to protein-misfolding diseases</article-title><source><italic>Nature</italic></source><year>2003</year><volume>426</volume><issue>6968</issue><fpage>905</fpage><lpage>909</lpage><pub-id pub-id-type="other">2-s2.0-0346727128</pub-id><pub-id pub-id-type="doi">10.1038/nature02265</pub-id><pub-id pub-id-type="pmid">14685252</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pepys</surname><given-names>M. B.</given-names></name><name><surname>Hirschfield</surname><given-names>G. M.</given-names></name></person-group><article-title>C-reactive protein: a critical update</article-title><source><italic>The Journal of Clinical Investigation</italic></source><year>2003</year><volume>111</volume><issue>12</issue><fpage>1805</fpage><lpage>1812</lpage><pub-id pub-id-type="doi">10.1172/jci200318921</pub-id><pub-id pub-id-type="other">2-s2.0-0042744797</pub-id><pub-id pub-id-type="pmid">12813013</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kisilevsky</surname><given-names>R.</given-names></name></person-group><article-title>The relation of proteoglycans, serum amyloid P and Apo E to amyloidosis current status, 2000</article-title><source><italic>Amyloid</italic></source><year>2000</year><volume>7</volume><issue>1</issue><fpage>23</fpage><lpage>25</lpage><pub-id pub-id-type="other">2-s2.0-0034110874</pub-id><pub-id pub-id-type="doi">10.3109/13506120009146820</pub-id><pub-id pub-id-type="pmid">10842701</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bellotti</surname><given-names>V.</given-names></name><name><surname>Chiti</surname><given-names>F.</given-names></name></person-group><article-title>Amyloidogenesis in its biological environment: challenging a fundamental issue in protein misfolding diseases</article-title><source><italic>Current Opinion in Structural Biology</italic></source><year>2008</year><volume>18</volume><issue>6</issue><fpage>771</fpage><lpage>779</lpage><pub-id pub-id-type="doi">10.1016/j.sbi.2008.10.001</pub-id><pub-id pub-id-type="other">2-s2.0-57049093241</pub-id><pub-id pub-id-type="pmid">18952166</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alexandrescu</surname><given-names>A. T.</given-names></name></person-group><article-title>Amyloid accomplices and enforcers</article-title><source><italic>Protein Science</italic></source><year>2005</year><volume>14</volume><issue>1</issue><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1110/ps.04887005</pub-id><pub-id pub-id-type="other">2-s2.0-11144221004</pub-id><pub-id pub-id-type="pmid">15576561</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ancsin</surname><given-names>J. B.</given-names></name></person-group><article-title>Amyloidogenesis: historical and modern observations point to heparan sulfate proteoglycans as a major culprit</article-title><source><italic>Amyloid</italic></source><year>2003</year><volume>10</volume><issue>2</issue><fpage>67</fpage><lpage>79</lpage><pub-id pub-id-type="doi">10.3109/13506120309041728</pub-id><pub-id pub-id-type="other">2-s2.0-0042703654</pub-id><pub-id pub-id-type="pmid">12964414</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gellermann</surname><given-names>G. P.</given-names></name><name><surname>Appel</surname><given-names>T. R.</given-names></name><name><surname>Tannert</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Raft lipids as common components of human extracellular amyloid fibrils</article-title><source><italic>Proceedings of the National Academy of Sciences of the United States of America</italic></source><year>2005</year><volume>102</volume><issue>18</issue><fpage>6297</fpage><lpage>6302</lpage><pub-id pub-id-type="other">2-s2.0-20944450871</pub-id><pub-id pub-id-type="doi">10.1073/pnas.0407035102</pub-id><pub-id pub-id-type="pmid">15851687</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Opie</surname><given-names>E. L.</given-names></name></person-group><article-title>The relation Oe diabetes mellitus to lesions of the pancreas. Hyaline degeneration of the islands Oe langerhans</article-title><source><italic>The Journal of Experimental Medicine</italic></source><year>1901</year><volume>5</volume><issue>5</issue><fpage>527</fpage><lpage>540</lpage><pub-id pub-id-type="doi">10.1084/jem.5.5.527</pub-id><pub-id pub-id-type="pmid">19866956</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bell</surname><given-names>E. T.</given-names></name></person-group><article-title>Hyalinization of the islets of Langerhans in nondiabetic individuals</article-title><source><italic>The American Journal of Pathology</italic></source><year>1959</year><volume>35</volume><issue>4</issue><fpage>801</fpage><lpage>805</lpage><pub-id pub-id-type="other">2-s2.0-0000611472</pub-id><pub-id pub-id-type="pmid">13670312</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ehrlich</surname><given-names>J. C.</given-names></name><name><surname>Ratner</surname><given-names>I. M.</given-names></name></person-group><article-title>Amyloidosis of the islets of Langerhans. A restudy of islet hyalin in diabetic and non-diabetic individuals</article-title><source><italic>The American Journal of Pathology</italic></source><year>1961</year><volume>38</volume><fpage>49</fpage><lpage>59</lpage><pub-id pub-id-type="other">2-s2.0-72949142071</pub-id><pub-id pub-id-type="pmid">13726023</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Westermark</surname><given-names>P.</given-names></name><name><surname>Wernstedt</surname><given-names>C.</given-names></name><name><surname>Wilander</surname><given-names>E.</given-names></name><name><surname>Hayden</surname><given-names>D. W.</given-names></name><name><surname>O'Brien</surname><given-names>T. D.</given-names></name><name><surname>Johnson</surname><given-names>K. H.</given-names></name></person-group><article-title>Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells</article-title><source><italic>Proceedings of the National Academy of Sciences of the United States of America</italic></source><year>1987</year><volume>84</volume><issue>11</issue><fpage>3881</fpage><lpage>3885</lpage><pub-id pub-id-type="doi">10.1073/pnas.84.11.3881</pub-id><pub-id pub-id-type="other">2-s2.0-0023192941</pub-id><pub-id pub-id-type="pmid">3035556</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cooper</surname><given-names>G. J. S.</given-names></name><name><surname>Willis</surname><given-names>A. C.</given-names></name><name><surname>Clark</surname><given-names>A.</given-names></name><name><surname>Turner</surname><given-names>R. C.</given-names></name><name><surname>Sim</surname><given-names>R. B.</given-names></name><name><surname>Reid</surname><given-names>K. B. M.</given-names></name></person-group><article-title>Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients</article-title><source><italic>Proceedings of the National Academy of Sciences of the United States of America</italic></source><year>1987</year><volume>84</volume><issue>23</issue><fpage>8628</fpage><lpage>8632</lpage><pub-id pub-id-type="doi">10.1073/pnas.84.23.8628</pub-id><pub-id pub-id-type="other">2-s2.0-0023579739</pub-id><pub-id pub-id-type="pmid">3317417</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lukinius</surname><given-names>A.</given-names></name><name><surname>Wilander</surname><given-names>E.</given-names></name><name><surname>Westermark</surname><given-names>G. T.</given-names></name><name><surname>Engstrom</surname><given-names>U.</given-names></name><name><surname>Westermark</surname><given-names>P.</given-names></name></person-group><article-title>Co-localization of islet amyloid polypeptide and insulin in the B cell secretory granules of the human pancreatic islets</article-title><source><italic>Diabetologia</italic></source><year>1989</year><volume>32</volume><issue>4</issue><fpage>240</fpage><lpage>244</lpage><pub-id pub-id-type="doi">10.1007/bf00285291</pub-id><pub-id pub-id-type="other">2-s2.0-0024307842</pub-id><pub-id pub-id-type="pmid">2668077</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jaikaran</surname><given-names>E. T. A. S.</given-names></name><name><surname>Nilsson</surname><given-names>M. R.</given-names></name><name><surname>Clark</surname><given-names>A.</given-names></name></person-group><article-title>Pancreatic <italic>&#946;</italic>-cell granule peptides form heteromolecular complexes which inhibit islet amyloid polypeptide fibril formation</article-title><source><italic>Biochemical Journal</italic></source><year>2004</year><volume>377</volume><issue>3</issue><fpage>709</fpage><lpage>716</lpage><pub-id pub-id-type="doi">10.1042/bj20030852</pub-id><pub-id pub-id-type="other">2-s2.0-1242292280</pub-id><pub-id pub-id-type="pmid">14565847</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Westermark</surname><given-names>P.</given-names></name></person-group><article-title>Amyloid in the islets of Langerhans: thoughts and some historical aspects</article-title><source><italic>Upsala Journal of Medical Sciences</italic></source><year>2011</year><volume>116</volume><issue>2</issue><fpage>81</fpage><lpage>89</lpage><pub-id pub-id-type="doi">10.3109/03009734.2011.573884</pub-id><pub-id pub-id-type="other">2-s2.0-79954510553</pub-id><pub-id pub-id-type="pmid">21486192</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brender</surname><given-names>J. R.</given-names></name><name><surname>Salamekh</surname><given-names>S.</given-names></name><name><surname>Ramamoorthy</surname><given-names>A.</given-names></name></person-group><article-title>Membrane disruption and early events in the aggregation of the diabetes related peptide IAPP from a molecular perspective</article-title><source><italic>Accounts of Chemical Research</italic></source><year>2012</year><volume>45</volume><issue>3</issue><fpage>454</fpage><lpage>462</lpage><pub-id pub-id-type="doi">10.1021/ar200189b</pub-id><pub-id pub-id-type="other">2-s2.0-84858632761</pub-id><pub-id pub-id-type="pmid">21942864</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khemt&#233;mourian</surname><given-names>L.</given-names></name><name><surname>Killian</surname><given-names>J. A.</given-names></name><name><surname>H&#246;ppener</surname><given-names>J. W.</given-names></name><name><surname>Engel</surname><given-names>M. F. M.</given-names></name></person-group><article-title>Recent insights in islet amyloid polypeptide-induced membrane disruption and its role in <italic>&#946;</italic>-cell death in type 2 diabetes mellitus</article-title><source><italic>Experimental Diabetes Research</italic></source><year>2008</year><volume>2008</volume><fpage>9</fpage><pub-id pub-id-type="publisher-id">421287</pub-id><pub-id pub-id-type="other">2-s2.0-44649150510</pub-id><pub-id pub-id-type="doi">10.1155/2008/421287</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Engel</surname><given-names>M. F. M.</given-names></name></person-group><article-title>Membrane permeabilization by Islet Amyloid Polypeptide</article-title><source><italic>Chemistry and Physics of Lipids</italic></source><year>2009</year><volume>160</volume><issue>1</issue><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1016/j.chemphyslip.2009.03.008</pub-id><pub-id pub-id-type="other">2-s2.0-67349142581</pub-id><pub-id pub-id-type="pmid">19501206</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>P.</given-names></name><name><surname>Marek</surname><given-names>P.</given-names></name><name><surname>Noor</surname><given-names>H.</given-names></name><etal/></person-group><article-title>Islet amyloid: from fundamental biophysics to mechanisms of cytotoxicity</article-title><source><italic>FEBS Letters</italic></source><year>2013</year><volume>587</volume><issue>8</issue><fpage>1106</fpage><lpage>1118</lpage><pub-id pub-id-type="other">2-s2.0-84876048693</pub-id><pub-id pub-id-type="doi">10.1016/j.febslet.2013.01.046</pub-id><pub-id pub-id-type="pmid">23380070</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hutton</surname><given-names>J. C.</given-names></name></person-group><article-title>Insulin secretory granule biogenesis and the proinsulin-processing endopeptidases</article-title><source><italic>Diabetologia</italic></source><year>1994</year><volume>37</volume><issue>supplement 2</issue><fpage>S48</fpage><lpage>S56</lpage><pub-id pub-id-type="doi">10.1007/bf00400826</pub-id><pub-id pub-id-type="other">2-s2.0-0027941216</pub-id><pub-id pub-id-type="pmid">7821740</pub-id></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Westermark</surname><given-names>P.</given-names></name><name><surname>Andersson</surname><given-names>A.</given-names></name><name><surname>Westermark</surname><given-names>G. T.</given-names></name></person-group><article-title>Islet amyloid polypeptide, islet amyloid, and diabetes mellitus</article-title><source><italic>Physiological Reviews</italic></source><year>2011</year><volume>91</volume><issue>3</issue><fpage>795</fpage><lpage>826</lpage><pub-id pub-id-type="doi">10.1152/physrev.00042.2009</pub-id><pub-id pub-id-type="other">2-s2.0-79954535899</pub-id><pub-id pub-id-type="pmid">21742788</pub-id></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Betsholtz</surname><given-names>C.</given-names></name><name><surname>Christmansson</surname><given-names>L.</given-names></name><name><surname>Engstrom</surname><given-names>U.</given-names></name><etal/></person-group><article-title>Sequence divergence in a specific region of islet amyloid polypeptide (IAPP) explains differences in islet amyloid formation between species</article-title><source><italic>FEBS Letters</italic></source><year>1989</year><volume>251</volume><issue>1-2</issue><fpage>261</fpage><lpage>264</lpage><pub-id pub-id-type="other">2-s2.0-0024400674</pub-id><pub-id pub-id-type="doi">10.1016/0014-5793(89)81467-x</pub-id><pub-id pub-id-type="pmid">2666169</pub-id></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Westermark</surname><given-names>P.</given-names></name><name><surname>Engstrom</surname><given-names>U.</given-names></name><name><surname>Johnson</surname><given-names>K. H.</given-names></name><name><surname>Westermark</surname><given-names>G. T.</given-names></name><name><surname>Betsholtz</surname><given-names>C.</given-names></name></person-group><article-title>Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation</article-title><source><italic>Proceedings of the National Academy of Sciences of the United States of America</italic></source><year>1990</year><volume>87</volume><issue>13</issue><fpage>5036</fpage><lpage>5040</lpage><pub-id pub-id-type="doi">10.1073/pnas.87.13.5036</pub-id><pub-id pub-id-type="other">2-s2.0-0025366838</pub-id><pub-id pub-id-type="pmid">2195544</pub-id></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williamson</surname><given-names>J. A.</given-names></name><name><surname>Miranker</surname><given-names>A. D.</given-names></name></person-group><article-title>Direct detection of transient alpha-helical states in islet amyloid polypeptide</article-title><source><italic>Protein Science</italic></source><year>2007</year><volume>16</volume><issue>1</issue><fpage>110</fpage><lpage>117</lpage><pub-id pub-id-type="doi">10.1110/ps.062486907</pub-id><pub-id pub-id-type="other">2-s2.0-33845960266</pub-id><pub-id pub-id-type="pmid">17123962</pub-id></element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dupuis</surname><given-names>N. F.</given-names></name><name><surname>Wu</surname><given-names>C.</given-names></name><name><surname>Shea</surname><given-names>J.-E.</given-names></name><name><surname>Bowers</surname><given-names>M. T.</given-names></name></person-group><article-title>Human islet amyloid polypeptide monomers form ordered <italic>&#946;</italic>-hairpins: a possible direct amyloidogenic precursor</article-title><source><italic>Journal of the American Chemical Society</italic></source><year>2009</year><volume>131</volume><issue>51</issue><fpage>18283</fpage><lpage>18292</lpage><pub-id pub-id-type="other">2-s2.0-73249115986</pub-id><pub-id pub-id-type="doi">10.1021/ja903814q</pub-id><pub-id pub-id-type="pmid">19950949</pub-id></element-citation></ref><ref id="B30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patil</surname><given-names>S. M.</given-names></name><name><surname>Xu</surname><given-names>S.</given-names></name><name><surname>Sheftic</surname><given-names>S. R.</given-names></name><name><surname>Alexandrescu</surname><given-names>A. T.</given-names></name></person-group><article-title>Dynamic <italic>&#945;</italic>-helix structure of micelle-bound human amylin</article-title><source><italic>The Journal of Biological Chemistry</italic></source><year>2009</year><volume>284</volume><issue>18</issue><fpage>11982</fpage><lpage>11991</lpage><pub-id pub-id-type="doi">10.1074/jbc.m809085200</pub-id><pub-id pub-id-type="other">2-s2.0-66449087200</pub-id><pub-id pub-id-type="pmid">19244249</pub-id></element-citation></ref><ref id="B31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nanga</surname><given-names>R. P. R.</given-names></name><name><surname>Brender</surname><given-names>J. R.</given-names></name><name><surname>Xu</surname><given-names>J.</given-names></name><name><surname>Hartman</surname><given-names>K.</given-names></name><name><surname>Subramanian</surname><given-names>V.</given-names></name><name><surname>Ramamoorthy</surname><given-names>A.</given-names></name></person-group><article-title>Three-dimensional structure and orientation of rat islet amyloid polypeptide protein in a membrane environment by solution NMR spectroscopy</article-title><source><italic>Journal of the American Chemical Society</italic></source><year>2009</year><volume>131</volume><issue>23</issue><fpage>8252</fpage><lpage>8261</lpage><pub-id pub-id-type="doi">10.1021/ja9010095</pub-id><pub-id pub-id-type="other">2-s2.0-67650533782</pub-id><pub-id pub-id-type="pmid">19456151</pub-id></element-citation></ref><ref id="B32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nanga</surname><given-names>R. P. R.</given-names></name><name><surname>Brender</surname><given-names>J. R.</given-names></name><name><surname>Vivekanandan</surname><given-names>S.</given-names></name><name><surname>Ramamoorthy</surname><given-names>A.</given-names></name></person-group><article-title>Structure and membrane orientation of IAPP in its natively amidated form at physiological pH in a membrane environment</article-title><source><italic>Biochimica et Biophysica Acta&#8212;Biomembranes</italic></source><year>2011</year><volume>1808</volume><issue>10</issue><fpage>2337</fpage><lpage>2342</lpage><pub-id pub-id-type="doi">10.1016/j.bbamem.2011.06.012</pub-id><pub-id pub-id-type="other">2-s2.0-79960449390</pub-id></element-citation></ref><ref id="B33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nanga</surname><given-names>R. P. R.</given-names></name><name><surname>Brender</surname><given-names>J. R.</given-names></name><name><surname>Xu</surname><given-names>J.</given-names></name><name><surname>Veglia</surname><given-names>G.</given-names></name><name><surname>Ramamoorthy</surname><given-names>A.</given-names></name></person-group><article-title>Structures of rat and human islet amyloid polypeptide IAPP<sub>1&#8722;19</sub> in micelles by NMR spectroscopy</article-title><source><italic>Biochemistry</italic></source><year>2008</year><volume>47</volume><issue>48</issue><fpage>12689</fpage><lpage>12697</lpage><pub-id pub-id-type="other">2-s2.0-57049174009</pub-id><pub-id pub-id-type="doi">10.1021/bi8014357</pub-id><pub-id pub-id-type="pmid">18989932</pub-id></element-citation></ref><ref id="B34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wimalawansa</surname><given-names>S. J.</given-names></name></person-group><article-title>Amylin, calcitonin gene-related peptide, calcitonin, and adrenomedullin: a peptide superfamily</article-title><source><italic>Critical Reviews in Neurobiology</italic></source><year>1997</year><volume>11</volume><issue>2-3</issue><fpage>167</fpage><lpage>239</lpage><pub-id pub-id-type="doi">10.1615/critrevneurobiol.v11.i2-3.40</pub-id><pub-id pub-id-type="other">2-s2.0-0030706031</pub-id><pub-id pub-id-type="pmid">9209829</pub-id></element-citation></ref><ref id="B35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chapter</surname><given-names>M. C.</given-names></name><name><surname>White</surname><given-names>C. M.</given-names></name><name><surname>DeRidder</surname><given-names>A.</given-names></name><name><surname>Chadwick</surname><given-names>W.</given-names></name><name><surname>Martin</surname><given-names>B.</given-names></name><name><surname>Maudsley</surname><given-names>S.</given-names></name></person-group><article-title>Chemical modification of class II G protein-coupled receptor ligands: frontiers in the development of peptide analogs as neuroendocrine pharmacological therapies</article-title><source><italic>Pharmacology &amp; Therapeutics</italic></source><year>2010</year><volume>125</volume><issue>1</issue><fpage>39</fpage><lpage>54</lpage><pub-id pub-id-type="doi">10.1016/j.pharmthera.2009.07.006</pub-id><pub-id pub-id-type="other">2-s2.0-72049097669</pub-id><pub-id pub-id-type="pmid">19686775</pub-id></element-citation></ref><ref id="B36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hay</surname><given-names>D. L.</given-names></name><name><surname>Poyner</surname><given-names>D. R.</given-names></name><name><surname>Sexton</surname><given-names>P. M.</given-names></name></person-group><article-title>GPCR modulation by RAMPs</article-title><source><italic>Pharmacology &amp; Therapeutics</italic></source><year>2006</year><volume>109</volume><issue>1-2</issue><fpage>173</fpage><lpage>197</lpage><pub-id pub-id-type="doi">10.1016/j.pharmthera.2005.06.015</pub-id><pub-id pub-id-type="other">2-s2.0-28444464430</pub-id><pub-id pub-id-type="pmid">16111761</pub-id></element-citation></ref><ref id="B37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Christopoulos</surname><given-names>G.</given-names></name><name><surname>Perry</surname><given-names>K. J.</given-names></name><name><surname>Morfis</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Multiple amylin receptors arise from receptor activity-modifying protein interaction with the calcitonin receptor gene product</article-title><source><italic>Molecular Pharmacology</italic></source><year>1999</year><volume>56</volume><issue>1</issue><fpage>235</fpage><lpage>242</lpage><pub-id pub-id-type="other">2-s2.0-0033039911</pub-id><pub-id pub-id-type="pmid">10385705</pub-id></element-citation></ref><ref id="B38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paxinos</surname><given-names>G.</given-names></name><name><surname>Chai</surname><given-names>S. Y.</given-names></name><name><surname>Christopoulos</surname><given-names>G.</given-names></name><etal/></person-group><article-title>In vitro autoradiographic localization of calcitonin and amylin binding sites in monkey brain</article-title><source><italic>Journal of Chemical Neuroanatomy</italic></source><year>2004</year><volume>27</volume><issue>4</issue><fpage>217</fpage><lpage>236</lpage><pub-id pub-id-type="other">2-s2.0-3142624611</pub-id><pub-id pub-id-type="doi">10.1016/j.jchemneu.2004.03.005</pub-id><pub-id pub-id-type="pmid">15261329</pub-id></element-citation></ref><ref id="B39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gedulin</surname><given-names>B. R.</given-names></name><name><surname>Rink</surname><given-names>T. J.</given-names></name><name><surname>Young</surname><given-names>A. A.</given-names></name></person-group><article-title>Dose-response for glucagonostatic effect of amylin in rats</article-title><source><italic>Metabolism: Clinical and Experimental</italic></source><year>1997</year><volume>46</volume><issue>1</issue><fpage>67</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1016/S0026-0495(97)90170-0</pub-id><pub-id pub-id-type="other">2-s2.0-0031037318</pub-id><pub-id pub-id-type="pmid">9005972</pub-id></element-citation></ref><ref id="B40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scherbaum</surname><given-names>W. A.</given-names></name></person-group><article-title>The role of amylin in the physiology of glycemic control</article-title><source><italic>Experimental and Clinical Endocrinology &amp; Diabetes</italic></source><year>1998</year><volume>106</volume><issue>2</issue><fpage>97</fpage><lpage>102</lpage><pub-id pub-id-type="doi">10.1055/s-0029-1211958</pub-id><pub-id pub-id-type="other">2-s2.0-0031981587</pub-id><pub-id pub-id-type="pmid">9628238</pub-id></element-citation></ref><ref id="B41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naot</surname><given-names>D.</given-names></name><name><surname>Cornish</surname><given-names>J.</given-names></name></person-group><article-title>The role of peptides and receptors of the calcitonin family in the regulation of bone metabolism</article-title><source><italic>Bone</italic></source><year>2008</year><volume>43</volume><issue>5</issue><fpage>813</fpage><lpage>818</lpage><pub-id pub-id-type="doi">10.1016/j.bone.2008.07.003</pub-id><pub-id pub-id-type="other">2-s2.0-53349180215</pub-id><pub-id pub-id-type="pmid">18687416</pub-id></element-citation></ref><ref id="B42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zidverc-Trajkovic</surname><given-names>J.</given-names></name><name><surname>Stanimirovic</surname><given-names>D.</given-names></name><name><surname>Obrenovic</surname><given-names>R.</given-names></name><etal/></person-group><article-title>Calcitonin gene-related peptide levels in saliva of patients with burning mouth syndrome</article-title><source><italic>Journal of Oral Pathology &amp; Medicine</italic></source><year>2009</year><volume>38</volume><issue>1</issue><fpage>29</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.1111/j.1600-0714.2008.00721.x</pub-id><pub-id pub-id-type="other">2-s2.0-58149156549</pub-id><pub-id pub-id-type="pmid">19192048</pub-id></element-citation></ref><ref id="B43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lutz</surname><given-names>T. A.</given-names></name></person-group><article-title>The role of amylin in the control of energy homeostasis</article-title><source><italic>American Journal of Physiology&#8212;Regulatory Integrative and Comparative Physiology</italic></source><year>2010</year><volume>298</volume><issue>6</issue><fpage>R1475</fpage><lpage>R1484</lpage><pub-id pub-id-type="doi">10.1152/ajpregu.00703.2009</pub-id><pub-id pub-id-type="other">2-s2.0-77952703708</pub-id></element-citation></ref><ref id="B44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tycko</surname><given-names>R.</given-names></name><name><surname>Wickner</surname><given-names>R. B.</given-names></name></person-group><article-title>Molecular structures of amyloid and prion fibrils: consensus versus controversy</article-title><source><italic>Accounts of Chemical Research</italic></source><year>2013</year><volume>46</volume><issue>7</issue><fpage>1487</fpage><lpage>1496</lpage><pub-id pub-id-type="doi">10.1021/ar300282r</pub-id><pub-id pub-id-type="other">2-s2.0-84874639389</pub-id><pub-id pub-id-type="pmid">23294335</pub-id></element-citation></ref><ref id="B45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nelson</surname><given-names>R.</given-names></name><name><surname>Sawaya</surname><given-names>M. R.</given-names></name><name><surname>Balbirnie</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Structure of the cross-<italic>&#946;</italic> spine of amyloid-like fibrils</article-title><source><italic>Nature</italic></source><year>2005</year><volume>435</volume><issue>7043</issue><fpage>773</fpage><lpage>778</lpage><pub-id pub-id-type="doi">10.1038/nature03680</pub-id><pub-id pub-id-type="other">2-s2.0-20444440728</pub-id><pub-id pub-id-type="pmid">15944695</pub-id></element-citation></ref><ref id="B46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Makin</surname><given-names>O. S.</given-names></name><name><surname>Serpell</surname><given-names>L. C.</given-names></name></person-group><article-title>Structures for amyloid fibrils</article-title><source><italic>The FEBS Journal</italic></source><year>2005</year><volume>272</volume><issue>23</issue><fpage>5950</fpage><lpage>5961</lpage><pub-id pub-id-type="other">2-s2.0-28244484729</pub-id><pub-id pub-id-type="doi">10.1111/j.1742-4658.2005.05025.x</pub-id><pub-id pub-id-type="pmid">16302960</pub-id></element-citation></ref><ref id="B47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petkova</surname><given-names>A. T.</given-names></name><name><surname>Leapman</surname><given-names>R. D.</given-names></name><name><surname>Guo</surname><given-names>Z.</given-names></name><name><surname>Yau</surname><given-names>W.-M.</given-names></name><name><surname>Mattson</surname><given-names>M. P.</given-names></name><name><surname>Tycko</surname><given-names>R.</given-names></name></person-group><article-title>Self-propagating, molecular-level polymorphism in Alzheimer's <italic>&#946;</italic>-amyloid fibrils</article-title><source><italic>Science</italic></source><year>2005</year><volume>307</volume><issue>5707</issue><fpage>262</fpage><lpage>265</lpage><pub-id pub-id-type="doi">10.1126/science.1105850</pub-id><pub-id pub-id-type="other">2-s2.0-12244249201</pub-id><pub-id pub-id-type="pmid">15653506</pub-id></element-citation></ref><ref id="B48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luca</surname><given-names>S.</given-names></name><name><surname>Yau</surname><given-names>W.-M.</given-names></name><name><surname>Leapman</surname><given-names>R.</given-names></name><name><surname>Tycko</surname><given-names>R.</given-names></name></person-group><article-title>Peptide conformation and supramolecular organization in amylin fibrils: constraints from solid-state NMR</article-title><source><italic>Biochemistry</italic></source><year>2007</year><volume>46</volume><issue>47</issue><fpage>13505</fpage><lpage>13522</lpage><pub-id pub-id-type="doi">10.1021/bi701427q</pub-id><pub-id pub-id-type="other">2-s2.0-36749033116</pub-id><pub-id pub-id-type="pmid">17979302</pub-id></element-citation></ref><ref id="B49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wiltzius</surname><given-names>J. J. W.</given-names></name><name><surname>Sievers</surname><given-names>S. A.</given-names></name><name><surname>Sawaya</surname><given-names>M. R.</given-names></name><etal/></person-group><article-title>Atomic structure of the cross-<italic>&#946;</italic> spine of islet amyloid polypeptide (amylin)</article-title><source><italic>Protein Science</italic></source><year>2008</year><volume>17</volume><issue>9</issue><fpage>1467</fpage><lpage>1474</lpage><pub-id pub-id-type="doi">10.1110/ps.036509.108</pub-id><pub-id pub-id-type="other">2-s2.0-50049095633</pub-id><pub-id pub-id-type="pmid">18556473</pub-id></element-citation></ref><ref id="B50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bedrood</surname><given-names>S.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Isas</surname><given-names>J. M.</given-names></name><etal/></person-group><article-title>Fibril structure of human islet amyloid polypeptide</article-title><source><italic>The Journal of Biological Chemistry</italic></source><year>2012</year><volume>287</volume><issue>8</issue><fpage>5235</fpage><lpage>5241</lpage><pub-id pub-id-type="other">2-s2.0-84863116618</pub-id><pub-id pub-id-type="doi">10.1074/jbc.m111.327817</pub-id><pub-id pub-id-type="pmid">22187437</pub-id></element-citation></ref><ref id="B51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shim</surname><given-names>S.-H.</given-names></name><name><surname>Gupta</surname><given-names>R.</given-names></name><name><surname>Ling</surname><given-names>Y. L.</given-names></name><name><surname>Strasfeld</surname><given-names>D. B.</given-names></name><name><surname>Raleigh</surname><given-names>D. P.</given-names></name><name><surname>Zanni</surname><given-names>M. T.</given-names></name></person-group><article-title>Two-dimensional IR spectroscopy and isotope labeling defines the pathway of amyloid formation with residue-specific resolution</article-title><source><italic>Proceedings of the National Academy of Sciences of the United States of America</italic></source><year>2009</year><volume>106</volume><issue>16</issue><fpage>6614</fpage><lpage>6619</lpage><pub-id pub-id-type="doi">10.1073/pnas.0805957106</pub-id><pub-id pub-id-type="other">2-s2.0-66149084447</pub-id><pub-id pub-id-type="pmid">19346479</pub-id></element-citation></ref><ref id="B52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kelly</surname><given-names>J. W.</given-names></name></person-group><article-title>Mechanisms of amyloidogenesis</article-title><source><italic>Nature Structural Biology</italic></source><year>2000</year><volume>7</volume><issue>10</issue><fpage>824</fpage><lpage>826</lpage><pub-id pub-id-type="other">2-s2.0-0033793872</pub-id><pub-id pub-id-type="doi">10.1038/82815</pub-id><pub-id pub-id-type="pmid">11017183</pub-id></element-citation></ref><ref id="B53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>J.</given-names></name><name><surname>Culyba</surname><given-names>E. K.</given-names></name><name><surname>Powers</surname><given-names>E. T.</given-names></name><name><surname>Kelly</surname><given-names>J. W.</given-names></name></person-group><article-title>Amyloid-<italic>&#946;</italic> forms fibrils by nucleated conformational conversion of oligomers</article-title><source><italic>Nature Chemical Biology</italic></source><year>2011</year><volume>7</volume><issue>9</issue><fpage>602</fpage><lpage>609</lpage><pub-id pub-id-type="doi">10.1038/nchembio.624</pub-id><pub-id pub-id-type="other">2-s2.0-84860389674</pub-id><pub-id pub-id-type="pmid">21804535</pub-id></element-citation></ref><ref id="B54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prusiner</surname><given-names>S. B.</given-names></name></person-group><article-title>Novel proteinaceous infectious particles cause scrapie</article-title><source><italic>Science</italic></source><year>1982</year><volume>216</volume><issue>4542</issue><fpage>136</fpage><lpage>144</lpage><pub-id pub-id-type="other">2-s2.0-0020321767</pub-id><pub-id pub-id-type="doi">10.1126/science.6801762</pub-id><pub-id pub-id-type="pmid">6801762</pub-id></element-citation></ref><ref id="B55"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harper</surname><given-names>J. D.</given-names></name><name><surname>Lansbury</surname><given-names>P. T.</given-names><suffix>Jr.</suffix></name></person-group><article-title>Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins</article-title><source><italic>Annual Review of Biochemistry</italic></source><year>1997</year><volume>66</volume><fpage>385</fpage><lpage>407</lpage><pub-id pub-id-type="doi">10.1146/annurev.biochem.66.1.385</pub-id><pub-id pub-id-type="other">2-s2.0-0030908095</pub-id></element-citation></ref><ref id="B56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bourgault</surname><given-names>S.</given-names></name><name><surname>Choi</surname><given-names>S.</given-names></name><name><surname>Buxbaum</surname><given-names>J. N.</given-names></name><name><surname>Kelly</surname><given-names>J. W.</given-names></name><name><surname>Price</surname><given-names>J. L.</given-names></name><name><surname>Reixach</surname><given-names>N.</given-names></name></person-group><article-title>Mechanisms of transthyretin cardiomyocyte toxicity inhibition by resveratrol analogs</article-title><source><italic>Biochemical and Biophysical Research Communications</italic></source><year>2011</year><volume>410</volume><fpage>707</fpage><lpage>713</lpage><pub-id pub-id-type="pmid">21557933</pub-id></element-citation></ref><ref id="B57"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kayed</surname><given-names>R.</given-names></name><name><surname>Head</surname><given-names>E.</given-names></name><name><surname>Thompson</surname><given-names>J. L.</given-names></name><etal/></person-group><article-title>Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis</article-title><source><italic>Science</italic></source><year>2003</year><volume>300</volume><issue>5618</issue><fpage>486</fpage><lpage>489</lpage><pub-id pub-id-type="doi">10.1126/science.1079469</pub-id><pub-id pub-id-type="other">2-s2.0-0242668337</pub-id><pub-id pub-id-type="pmid">12702875</pub-id></element-citation></ref><ref id="B58"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bemporad</surname><given-names>F.</given-names></name><name><surname>Chiti</surname><given-names>F.</given-names></name></person-group><article-title>Protein misfolded oligomers: experimental approaches, mechanism of formation, and structure-toxicity relationships</article-title><source><italic>Chemistry &amp; Biology</italic></source><year>2012</year><volume>19</volume><issue>3</issue><fpage>315</fpage><lpage>327</lpage><pub-id pub-id-type="other">2-s2.0-84858978818</pub-id><pub-id pub-id-type="doi">10.1016/j.chembiol.2012.02.003</pub-id><pub-id pub-id-type="pmid">22444587</pub-id></element-citation></ref><ref id="B59"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abedini</surname><given-names>A.</given-names></name><name><surname>Raleigh</surname><given-names>D. P.</given-names></name></person-group><article-title>A critical assessment of the role of helical intermediates in amyloid formation by natively unfolded proteins and polypeptides</article-title><source><italic>Protein Engineering, Design &amp; Selection</italic></source><year>2009</year><volume>22</volume><issue>8</issue><fpage>453</fpage><lpage>459</lpage><pub-id pub-id-type="doi">10.1093/protein/gzp036</pub-id><pub-id pub-id-type="other">2-s2.0-70349218070</pub-id></element-citation></ref><ref id="B60"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dupuis</surname><given-names>N. F.</given-names></name><name><surname>Wu</surname><given-names>C.</given-names></name><name><surname>Shea</surname><given-names>J.-E.</given-names></name><name><surname>Bowers</surname><given-names>M. T.</given-names></name></person-group><article-title>The amyloid formation mechanism in human IAPP: dimers have beta-strand monomer-monomer interfaces</article-title><source><italic>Journal of the American Chemical Society</italic></source><year>2011</year><volume>133</volume><issue>19</issue><fpage>7240</fpage><lpage>7243</lpage><pub-id pub-id-type="doi">10.1021/ja1081537</pub-id><pub-id pub-id-type="other">2-s2.0-79955896407</pub-id><pub-id pub-id-type="pmid">21517093</pub-id></element-citation></ref><ref id="B61"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ling</surname><given-names>Y. L.</given-names></name><name><surname>Strasfeld</surname><given-names>D. B.</given-names></name><name><surname>Shim</surname><given-names>S.-H.</given-names></name><name><surname>Raleigh</surname><given-names>D. P.</given-names></name><name><surname>Zanni</surname><given-names>M. T.</given-names></name></person-group><article-title>Two-dimensional infrared spectroscopy provides evidence of an intermediate in the membrane-catalyzed assembly of diabetic amyloid</article-title><source><italic>The Journal of Physical Chemistry B</italic></source><year>2009</year><volume>113</volume><issue>8</issue><fpage>2498</fpage><lpage>2505</lpage><pub-id pub-id-type="other">2-s2.0-65249173508</pub-id><pub-id pub-id-type="doi">10.1021/jp810261x</pub-id><pub-id pub-id-type="pmid">19182939</pub-id></element-citation></ref><ref id="B62"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Padrick</surname><given-names>S. B.</given-names></name><name><surname>Miranker</surname><given-names>A. D.</given-names></name></person-group><article-title>Islet amyloid: phase partitioning and secondary nucleation are central to the mechanism of fibrillogenesis</article-title><source><italic>Biochemistry</italic></source><year>2002</year><volume>41</volume><issue>14</issue><fpage>4694</fpage><lpage>4703</lpage><pub-id pub-id-type="other">2-s2.0-0037046151</pub-id><pub-id pub-id-type="doi">10.1021/bi0160462</pub-id><pub-id pub-id-type="pmid">11926832</pub-id></element-citation></ref><ref id="B63"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yanagi</surname><given-names>K.</given-names></name><name><surname>Ashizaki</surname><given-names>M.</given-names></name><name><surname>Yagi</surname><given-names>H.</given-names></name><name><surname>Sakurai</surname><given-names>K.</given-names></name><name><surname>Lee</surname><given-names>Y.-H.</given-names></name><name><surname>Goto</surname><given-names>Y.</given-names></name></person-group><article-title>Hexafluoroisopropanol induces amyloid fibrils of islet amyloid polypeptide by enhancing both hydrophobic and electrostatic interactions</article-title><source><italic>The Journal of Biological Chemistry</italic></source><year>2011</year><volume>286</volume><issue>27</issue><fpage>23959</fpage><lpage>23966</lpage><pub-id pub-id-type="doi">10.1074/jbc.m111.226688</pub-id><pub-id pub-id-type="other">2-s2.0-79959865248</pub-id><pub-id pub-id-type="pmid">21566116</pub-id></element-citation></ref><ref id="B64"><label>64</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knight</surname><given-names>J. D.</given-names></name><name><surname>Miranker</surname><given-names>A. D.</given-names></name></person-group><article-title>Phospholipid catalysis of diabetic amyloid assembly</article-title><source><italic>Journal of Molecular Biology</italic></source><year>2004</year><volume>341</volume><issue>5</issue><fpage>1175</fpage><lpage>1187</lpage><pub-id pub-id-type="doi">10.1016/j.jmb.2004.06.086</pub-id><pub-id pub-id-type="other">2-s2.0-4143094106</pub-id><pub-id pub-id-type="pmid">15321714</pub-id></element-citation></ref><ref id="B65"><label>65</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saraogi</surname><given-names>I.</given-names></name><name><surname>Hebda</surname><given-names>J. A.</given-names></name><name><surname>Becerril</surname><given-names>J.</given-names></name><name><surname>Estroff</surname><given-names>L. A.</given-names></name><name><surname>Miranker</surname><given-names>A. D.</given-names></name><name><surname>Hamilton</surname><given-names>A. D.</given-names></name></person-group><article-title>Synthetic <italic>&#945;</italic>-helix mimetics as agonists and antagonists of islet amyloid polypeptide aggregation</article-title><source><italic>Angewandte Chemie&#8212;International Edition</italic></source><year>2010</year><volume>49</volume><issue>4</issue><fpage>736</fpage><lpage>739</lpage><pub-id pub-id-type="doi">10.1002/anie.200901694</pub-id><pub-id pub-id-type="other">2-s2.0-74849110603</pub-id><pub-id pub-id-type="pmid">20029853</pub-id></element-citation></ref><ref id="B66"><label>66</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>S.</given-names></name><name><surname>Brown</surname><given-names>M. A.</given-names></name><name><surname>Nath</surname><given-names>A.</given-names></name><name><surname>Miranker</surname><given-names>A. D.</given-names></name></person-group><article-title>Folded small molecule manipulation of islet amyloid polypeptide</article-title><source><italic>Chemistry &amp; Biology</italic></source><year>2014</year><volume>21</volume><issue>6</issue><fpage>775</fpage><lpage>781</lpage><pub-id pub-id-type="doi">10.1016/j.chembiol.2014.05.007</pub-id><pub-id pub-id-type="pmid">24930968</pub-id></element-citation></ref><ref id="B67"><label>67</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>S.</given-names></name><name><surname>Miranker</surname><given-names>A. D.</given-names></name></person-group><article-title>A foldamer approach to targeting membrane bound helical states of islet amyloid polypeptide</article-title><source><italic>Chemical Communications (Cambridge, England)</italic></source><year>2013</year><volume>49</volume><issue>42</issue><fpage>4749</fpage><lpage>4751</lpage><pub-id pub-id-type="other">2-s2.0-84877250900</pub-id><pub-id pub-id-type="doi">10.1039/c3cc41452c</pub-id></element-citation></ref><ref id="B68"><label>68</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hassanpour</surname><given-names>A.</given-names></name><name><surname>de Carufel</surname><given-names>C. A.</given-names></name><name><surname>Bourgault</surname><given-names>S.</given-names></name><name><surname>Forgione</surname><given-names>P.</given-names></name></person-group><article-title>Synthesis of 2,5-diaryl-substituted thiophenes as helical mimetics: towards the modulation of islet amyloid polypeptide (IAPP) amyloid fibril formation and cytotoxicity</article-title><source><italic>Chemistry</italic></source><year>2014</year><volume>20</volume><issue>9</issue><fpage>2522</fpage><lpage>2528</lpage><pub-id pub-id-type="other">2-s2.0-84897658419</pub-id><pub-id pub-id-type="doi">10.1002/chem.201303928</pub-id><pub-id pub-id-type="pmid">24488624</pub-id></element-citation></ref><ref id="B69"><label>69</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Young</surname><given-names>I. D.</given-names></name><name><surname>Ailles</surname><given-names>L.</given-names></name><name><surname>Narindrasorasak</surname><given-names>S.</given-names></name><name><surname>Tan</surname><given-names>R.</given-names></name><name><surname>Kisilevsky</surname><given-names>R.</given-names></name></person-group><article-title>Localization of the basement membrane heparan sulfate proteoglycan in islet amyloid deposits in type II diabetes mellitus</article-title><source><italic>Archives of Pathology &amp; Laboratory Medicine</italic></source><year>1992</year><volume>116</volume><issue>9</issue><fpage>951</fpage><lpage>954</lpage><pub-id pub-id-type="other">2-s2.0-0026688125</pub-id><pub-id pub-id-type="pmid">1524461</pub-id></element-citation></ref><ref id="B70"><label>70</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hull</surname><given-names>R. L.</given-names></name><name><surname>Zraika</surname><given-names>S.</given-names></name><name><surname>Udayasankar</surname><given-names>J.</given-names></name><etal/></person-group><article-title>Inhibition of glycosaminoglycan synthesis and protein glycosylation with WAS-406 and azaserine result in reduced islet amyloid formation in vitro</article-title><source><italic>American Journal of Physiology&#8212;Cell Physiology</italic></source><year>2007</year><volume>293</volume><issue>5</issue><fpage>C1586</fpage><lpage>C1593</lpage><pub-id pub-id-type="doi">10.1152/ajpcell.00208.2007</pub-id><pub-id pub-id-type="other">2-s2.0-36048998707</pub-id><pub-id pub-id-type="pmid">17804609</pub-id></element-citation></ref><ref id="B71"><label>71</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Westermark</surname><given-names>G. T.</given-names></name><name><surname>Westermark</surname><given-names>P.</given-names></name></person-group><article-title>Localized amyloids important in diseases outside the brain&#8212;lessons from the islets of Langerhans and the thoracic aorta</article-title><source><italic>The FEBS Journal</italic></source><year>2011</year><volume>278</volume><issue>20</issue><fpage>3918</fpage><lpage>3929</lpage><pub-id pub-id-type="doi">10.1111/j.1742-4658.2011.08298.x</pub-id><pub-id pub-id-type="other">2-s2.0-80053610643</pub-id><pub-id pub-id-type="pmid">21834879</pub-id></element-citation></ref><ref id="B72"><label>72</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Castillo</surname><given-names>G. M.</given-names></name><name><surname>Cummings</surname><given-names>J. A.</given-names></name><name><surname>Yang</surname><given-names>W.</given-names></name><etal/></person-group><article-title>Sulfate content and specific glycosaminoglycan backbone of perlecan are critical for perlecan's enhancement of islet amyloid polypeptide (amylin) fibril formation</article-title><source><italic>Diabetes</italic></source><year>1998</year><volume>47</volume><issue>4</issue><fpage>612</fpage><lpage>620</lpage><pub-id pub-id-type="doi">10.2337/diabetes.47.4.612</pub-id><pub-id pub-id-type="other">2-s2.0-0031895939</pub-id><pub-id pub-id-type="pmid">9568695</pub-id></element-citation></ref><ref id="B73"><label>73</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jha</surname><given-names>S.</given-names></name><name><surname>Patil</surname><given-names>S. M.</given-names></name><name><surname>Gibson</surname><given-names>J.</given-names></name><name><surname>Nelson</surname><given-names>C. E.</given-names></name><name><surname>Alder</surname><given-names>N. N.</given-names></name><name><surname>Alexandrescu</surname><given-names>A. T.</given-names></name></person-group><article-title>Mechanism of amylin fibrillization enhancement by heparin</article-title><source><italic>The Journal of Biological Chemistry</italic></source><year>2011</year><volume>286</volume><issue>26</issue><fpage>22894</fpage><lpage>22904</lpage><pub-id pub-id-type="doi">10.1074/jbc.m110.215814</pub-id><pub-id pub-id-type="other">2-s2.0-79959544813</pub-id><pub-id pub-id-type="pmid">21555785</pub-id></element-citation></ref><ref id="B74"><label>74</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Cao</surname><given-names>P.</given-names></name><name><surname>Raleigh</surname><given-names>D. P.</given-names></name></person-group><article-title>Amyloid formation in heterogeneous environments: islet amyloid polypeptide glycosaminoglycan interactions</article-title><source><italic>Journal of Molecular Biology</italic></source><year>2013</year><volume>425</volume><issue>3</issue><fpage>492</fpage><lpage>505</lpage><pub-id pub-id-type="doi">10.1016/j.jmb.2012.11.003</pub-id><pub-id pub-id-type="other">2-s2.0-84872849919</pub-id><pub-id pub-id-type="pmid">23154166</pub-id></element-citation></ref><ref id="B75"><label>75</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Carufel</surname><given-names>C. A.</given-names></name><name><surname>Nguyen</surname><given-names>P. T.</given-names></name><name><surname>Sahnouni</surname><given-names>S.</given-names></name><name><surname>Bourgault</surname><given-names>S.</given-names></name></person-group><article-title>New insights into the roles of sulfated glycosaminoglycans in islet amyloid polypeptide amyloidogenesis and cytotoxicity</article-title><source><italic>Biopolymers</italic></source><year>2013</year><volume>100</volume><issue>6</issue><fpage>645</fpage><lpage>655</lpage><pub-id pub-id-type="other">2-s2.0-84891673810</pub-id><pub-id pub-id-type="doi">10.1002/bip.22243</pub-id><pub-id pub-id-type="pmid">23526456</pub-id></element-citation></ref><ref id="B76"><label>76</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Konno</surname><given-names>T.</given-names></name><name><surname>Oiki</surname><given-names>S.</given-names></name><name><surname>Morii</surname><given-names>T.</given-names></name></person-group><article-title>Synergistic action of polyanionic and non-polar cofactors in fibrillation of human islet amyloid polypeptide</article-title><source><italic>FEBS Letters</italic></source><year>2007</year><volume>581</volume><issue>8</issue><fpage>1635</fpage><lpage>1638</lpage><pub-id pub-id-type="doi">10.1016/j.febslet.2007.03.030</pub-id><pub-id pub-id-type="other">2-s2.0-34047174621</pub-id><pub-id pub-id-type="pmid">17399708</pub-id></element-citation></ref><ref id="B77"><label>77</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abedini</surname><given-names>A.</given-names></name><name><surname>Tracz</surname><given-names>S. M.</given-names></name><name><surname>Cho</surname><given-names>J.-H.</given-names></name><name><surname>Raleigh</surname><given-names>D. P.</given-names></name></person-group><article-title>Characterization of the heparin binding site in the N-terminus of human pro-islet amyloid polypeptide: implications for amyloid formation</article-title><source><italic>Biochemistry</italic></source><year>2006</year><volume>45</volume><issue>30</issue><fpage>9228</fpage><lpage>9237</lpage><pub-id pub-id-type="doi">10.1021/bi0510936</pub-id><pub-id pub-id-type="other">2-s2.0-33746614282</pub-id><pub-id pub-id-type="pmid">16866369</pub-id></element-citation></ref><ref id="B78"><label>78</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bishop</surname><given-names>J. R.</given-names></name><name><surname>Schuksz</surname><given-names>M.</given-names></name><name><surname>Esko</surname><given-names>J. D.</given-names></name></person-group><article-title>Heparan sulphate proteoglycans fine-tune mammalian physiology</article-title><source><italic>Nature</italic></source><year>2007</year><volume>446</volume><issue>7139</issue><fpage>1030</fpage><lpage>1037</lpage><pub-id pub-id-type="doi">10.1038/nature05817</pub-id><pub-id pub-id-type="other">2-s2.0-34247610845</pub-id><pub-id pub-id-type="pmid">17460664</pub-id></element-citation></ref><ref id="B79"><label>79</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moremen</surname><given-names>K. W.</given-names></name><name><surname>Tiemeyer</surname><given-names>M.</given-names></name><name><surname>Nairn</surname><given-names>A. V.</given-names></name></person-group><article-title>Vertebrate protein glycosylation: diversity, synthesis and function</article-title><source><italic>Nature Reviews Molecular Cell Biology</italic></source><year>2012</year><volume>13</volume><issue>7</issue><fpage>448</fpage><lpage>462</lpage><pub-id pub-id-type="other">2-s2.0-84862728161</pub-id><pub-id pub-id-type="doi">10.1038/nrm3383</pub-id><pub-id pub-id-type="pmid">22722607</pub-id></element-citation></ref><ref id="B80"><label>80</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Handel</surname><given-names>T. M.</given-names></name><name><surname>Johnson</surname><given-names>Z.</given-names></name><name><surname>Crown</surname><given-names>S. E.</given-names></name><name><surname>Lau</surname><given-names>E. K.</given-names></name><name><surname>Sweeney</surname><given-names>M.</given-names></name><name><surname>Proudfoot</surname><given-names>A. E.</given-names></name></person-group><article-title>Regulation of protein function by glycosaminoglycans&#8212;as exemplified by chemokines</article-title><source><italic>Annual Review of Biochemistry</italic></source><year>2005</year><volume>74</volume><fpage>385</fpage><lpage>410</lpage><pub-id pub-id-type="other">2-s2.0-22244448718</pub-id><pub-id pub-id-type="doi">10.1146/annurev.biochem.72.121801.161747</pub-id></element-citation></ref><ref id="B81"><label>81</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ihrcke</surname><given-names>N. S.</given-names></name><name><surname>Wrenshall</surname><given-names>L. E.</given-names></name><name><surname>Lindman</surname><given-names>B. J.</given-names></name><name><surname>Platt</surname><given-names>J. L.</given-names></name></person-group><article-title>Role of heparan sulfate in immune system-blood vessel interactions</article-title><source><italic>Immunology Today</italic></source><year>1993</year><volume>14</volume><issue>10</issue><fpage>500</fpage><lpage>505</lpage><pub-id pub-id-type="doi">10.1016/0167-5699(93)90265-m</pub-id><pub-id pub-id-type="other">2-s2.0-0027377719</pub-id><pub-id pub-id-type="pmid">8274190</pub-id></element-citation></ref><ref id="B82"><label>82</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Esko</surname><given-names>J. D.</given-names></name><name><surname>Selleck</surname><given-names>S. B.</given-names></name></person-group><article-title>Order out of chaos: assembly of ligand binding sites in heparan sulfate</article-title><source><italic>Annual Review of Biochemistry</italic></source><year>2002</year><volume>71</volume><fpage>435</fpage><lpage>471</lpage><pub-id pub-id-type="doi">10.1146/annurev.biochem.71.110601.135458</pub-id><pub-id pub-id-type="other">2-s2.0-0035997376</pub-id></element-citation></ref><ref id="B83"><label>83</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McLaurin</surname><given-names>J.</given-names></name><name><surname>Franklin</surname><given-names>T.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Deng</surname><given-names>J.</given-names></name><name><surname>Fraser</surname><given-names>P. E.</given-names></name></person-group><article-title>Interactions of Alzheimer amyloid-<italic>&#946;</italic> peptides with glycosaminoglycans: effects on fibril nucleation and growth</article-title><source><italic>European Journal of Biochemistry</italic></source><year>1999</year><volume>266</volume><issue>3</issue><fpage>1101</fpage><lpage>1110</lpage><pub-id pub-id-type="doi">10.1046/j.1432-1327.1999.00957.x</pub-id><pub-id pub-id-type="other">2-s2.0-0033572813</pub-id><pub-id pub-id-type="pmid">10583407</pub-id></element-citation></ref><ref id="B84"><label>84</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cohlberg</surname><given-names>J. A.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Uversky</surname><given-names>V. N.</given-names></name><name><surname>Fink</surname><given-names>A. L.</given-names></name></person-group><article-title>Heparin and other glycosaminoglycans stimulate the formation of amyloid fibrils from <italic>&#945;</italic>-synuclein in vitro</article-title><source><italic>Biochemistry</italic></source><year>2002</year><volume>41</volume><issue>5</issue><fpage>1502</fpage><lpage>1511</lpage><pub-id pub-id-type="doi">10.1021/bi011711s</pub-id><pub-id pub-id-type="other">2-s2.0-0037022186</pub-id><pub-id pub-id-type="pmid">11814343</pub-id></element-citation></ref><ref id="B85"><label>85</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bourgault</surname><given-names>S.</given-names></name><name><surname>Solomon</surname><given-names>J. P.</given-names></name><name><surname>Reixach</surname><given-names>N.</given-names></name><name><surname>Kelly</surname><given-names>J. W.</given-names></name></person-group><article-title>Sulfated glycosaminoglycans accelerate transthyretin amyloidogenesis by quaternary structural conversion</article-title><source><italic>Biochemistry</italic></source><year>2011</year><volume>50</volume><issue>6</issue><fpage>1001</fpage><lpage>1015</lpage><pub-id pub-id-type="doi">10.1021/bi101822y</pub-id><pub-id pub-id-type="other">2-s2.0-79851492876</pub-id><pub-id pub-id-type="pmid">21194234</pub-id></element-citation></ref><ref id="B86"><label>86</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Solomon</surname><given-names>J. P.</given-names></name><name><surname>Bourgault</surname><given-names>S.</given-names></name><name><surname>Powers</surname><given-names>E. T.</given-names></name><name><surname>Kelly</surname><given-names>J. W.</given-names></name></person-group><article-title>Heparin binds 8 kDa gelsolin cross-<italic>&#946;</italic>-sheet oligomers and accelerates amyloidogenesis by hastening fibril extension</article-title><source><italic>Biochemistry</italic></source><year>2011</year><volume>50</volume><issue>13</issue><fpage>2486</fpage><lpage>2498</lpage><pub-id pub-id-type="doi">10.1021/bi101905n</pub-id><pub-id pub-id-type="other">2-s2.0-79953179308</pub-id><pub-id pub-id-type="pmid">21348501</pub-id></element-citation></ref><ref id="B87"><label>87</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Relini</surname><given-names>A.</given-names></name><name><surname>de Stefano</surname><given-names>S.</given-names></name><name><surname>Torrassa</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Heparin strongly enhances the formation of <italic>&#946;</italic>
<sub>2</sub>-microglobulin amyloid fibrils in the presence of type I collagen</article-title><source><italic>The Journal of Biological Chemistry</italic></source><year>2008</year><volume>283</volume><issue>8</issue><fpage>4912</fpage><lpage>4920</lpage><pub-id pub-id-type="other">2-s2.0-41949084293</pub-id><pub-id pub-id-type="doi">10.1074/jbc.m702712200</pub-id><pub-id pub-id-type="pmid">18056266</pub-id></element-citation></ref><ref id="B88"><label>88</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Motamedi-Shad</surname><given-names>N.</given-names></name><name><surname>Monsellier</surname><given-names>E.</given-names></name><name><surname>Torrasa</surname><given-names>S.</given-names></name><name><surname>Relini</surname><given-names>A.</given-names></name><name><surname>Chiti</surname><given-names>F.</given-names></name></person-group><article-title>Kinetic analysis of amyloid formation in the presence of heparan sulfate: faster unfolding and change of pathway</article-title><source><italic>The Journal of Biological Chemistry</italic></source><year>2009</year><volume>284</volume><issue>43</issue><fpage>29921</fpage><lpage>29934</lpage><pub-id pub-id-type="doi">10.1074/jbc.m109.018747</pub-id><pub-id pub-id-type="other">2-s2.0-70350371594</pub-id><pub-id pub-id-type="pmid">19700762</pub-id></element-citation></ref><ref id="B89"><label>89</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suk</surname><given-names>J. Y.</given-names></name><name><surname>Zhang</surname><given-names>F.</given-names></name><name><surname>Balch</surname><given-names>W. E.</given-names></name><name><surname>Linhardt</surname><given-names>R. J.</given-names></name><name><surname>Kelly</surname><given-names>J. W.</given-names></name></person-group><article-title>Heparin accelerates gelsolin amyloidogenesis</article-title><source><italic>Biochemistry</italic></source><year>2006</year><volume>45</volume><issue>7</issue><fpage>2234</fpage><lpage>2242</lpage><pub-id pub-id-type="doi">10.1021/bi0519295</pub-id><pub-id pub-id-type="other">2-s2.0-33144470924</pub-id><pub-id pub-id-type="pmid">16475811</pub-id></element-citation></ref><ref id="B90"><label>90</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>K.</given-names></name><name><surname>Verchere</surname><given-names>C. B.</given-names></name></person-group><article-title>Identification of a heparin binding domain in the N-terminal cleavage site of pro-islet amyloid polypeptide. Implications for islet amyloid formation</article-title><source><italic>The Journal of Biological Chemistry</italic></source><year>2001</year><volume>276</volume><issue>20</issue><fpage>16611</fpage><lpage>16616</lpage><pub-id pub-id-type="doi">10.1074/jbc.m008423200</pub-id><pub-id pub-id-type="other">2-s2.0-0035907265</pub-id><pub-id pub-id-type="pmid">11145957</pub-id></element-citation></ref><ref id="B91"><label>91</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hull</surname><given-names>R. L.</given-names></name><name><surname>Peters</surname><given-names>M. J.</given-names></name><name><surname>Perigo</surname><given-names>S. P.</given-names></name><name><surname>Chan</surname><given-names>C. K.</given-names></name><name><surname>Wight</surname><given-names>T. N.</given-names></name><name><surname>Kinsella</surname><given-names>M. G.</given-names></name></person-group><article-title>Overall sulfation of heparan sulfate from pancreatic islet <italic>&#946;</italic>-TC3 cells increases maximal fibril formation but does not determine binding to the amyloidogenic peptide islet amyloid polypeptide</article-title><source><italic>The Journal of Biological Chemistry</italic></source><year>2012</year><volume>287</volume><issue>44</issue><fpage>37154</fpage><lpage>37164</lpage><pub-id pub-id-type="other">2-s2.0-84868217010</pub-id><pub-id pub-id-type="doi">10.1074/jbc.m112.409847</pub-id><pub-id pub-id-type="pmid">22936797</pub-id></element-citation></ref><ref id="B92"><label>92</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meng</surname><given-names>F.</given-names></name><name><surname>Abedini</surname><given-names>A.</given-names></name><name><surname>Song</surname><given-names>B.</given-names></name><name><surname>Raleigh</surname><given-names>D. P.</given-names></name></person-group><article-title>Amyloid formation by pro-islet amyloid polypeptide processing intermediates: examination of the role of protein heparan sulfate interactions and implications for islet amyloid formation in type 2 diabetes</article-title><source><italic>Biochemistry</italic></source><year>2007</year><volume>46</volume><issue>43</issue><fpage>12091</fpage><lpage>12099</lpage><pub-id pub-id-type="other">2-s2.0-35648975218</pub-id><pub-id pub-id-type="doi">10.1021/bi7004834</pub-id><pub-id pub-id-type="pmid">17924651</pub-id></element-citation></ref><ref id="B93"><label>93</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Noy</surname><given-names>D.</given-names></name><name><surname>Solomonov</surname><given-names>I.</given-names></name><name><surname>Sinkevich</surname><given-names>O.</given-names></name><name><surname>Arad</surname><given-names>T.</given-names></name><name><surname>Kjaer</surname><given-names>K.</given-names></name><name><surname>Sagi</surname><given-names>I.</given-names></name></person-group><article-title>Zinc-amyloid <italic>&#946;</italic> interactions on a millisecond time-scale stabilize non-fibrillar Alzheimer-related species</article-title><source><italic>Journal of the American Chemical Society</italic></source><year>2008</year><volume>130</volume><issue>4</issue><fpage>1376</fpage><lpage>1383</lpage><pub-id pub-id-type="other">2-s2.0-38649112930</pub-id><pub-id pub-id-type="doi">10.1021/ja076282l</pub-id><pub-id pub-id-type="pmid">18179213</pub-id></element-citation></ref><ref id="B94"><label>94</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamin</surname><given-names>G.</given-names></name><name><surname>Glaser</surname><given-names>C. B.</given-names></name><name><surname>Uversky</surname><given-names>V. N.</given-names></name><name><surname>Fink</surname><given-names>A. L.</given-names></name></person-group><article-title>Certain metals trigger fibrillation of methionine-oxidized <italic>&#945;</italic>-synuclein</article-title><source><italic>The Journal of Biological Chemistry</italic></source><year>2003</year><volume>278</volume><issue>30</issue><fpage>27630</fpage><lpage>27635</lpage><pub-id pub-id-type="other">2-s2.0-0041845349</pub-id><pub-id pub-id-type="doi">10.1074/jbc.m303302200</pub-id><pub-id pub-id-type="pmid">12754258</pub-id></element-citation></ref><ref id="B95"><label>95</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calabrese</surname><given-names>M. F.</given-names></name><name><surname>Eakin</surname><given-names>C. M.</given-names></name><name><surname>Wang</surname><given-names>J. M.</given-names></name><name><surname>Miranker</surname><given-names>A. D.</given-names></name></person-group><article-title>A regulatable switch mediates self-association in an immunoglobulin fold</article-title><source><italic>Nature Structural &amp; Molecular Biology</italic></source><year>2008</year><volume>15</volume><issue>9</issue><fpage>965</fpage><lpage>971</lpage><pub-id pub-id-type="doi">10.1038/nsmb.1483</pub-id><pub-id pub-id-type="other">2-s2.0-51349128031</pub-id></element-citation></ref><ref id="B96"><label>96</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hane</surname><given-names>F.</given-names></name><name><surname>Leonenko</surname><given-names>Z.</given-names></name></person-group><article-title>Effect of metals on kinetic pathways of amyloid-beta aggregation</article-title><source><italic>Biomolecules</italic></source><year>2014</year><volume>4</volume><issue>1</issue><fpage>101</fpage><lpage>116</lpage><pub-id pub-id-type="doi">10.3390/biom4010101</pub-id><pub-id pub-id-type="pmid">24970207</pub-id></element-citation></ref><ref id="B97"><label>97</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Foster</surname><given-names>M. C.</given-names></name><name><surname>Leapman</surname><given-names>R. D.</given-names></name><name><surname>Li</surname><given-names>M. X.</given-names></name><name><surname>Atwater</surname><given-names>I.</given-names></name></person-group><article-title>Elemental composition of secretory granules in pancreatic islets of Langerhans</article-title><source><italic>Biophysical Journal</italic></source><year>1993</year><volume>64</volume><issue>2</issue><fpage>525</fpage><lpage>532</lpage><pub-id pub-id-type="doi">10.1016/s0006-3495(93)81397-3</pub-id><pub-id pub-id-type="other">2-s2.0-0027453033</pub-id><pub-id pub-id-type="pmid">8457676</pub-id></element-citation></ref><ref id="B98"><label>98</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brender</surname><given-names>J. R.</given-names></name><name><surname>Hartman</surname><given-names>K.</given-names></name><name><surname>Nanga</surname><given-names>R. P. R.</given-names></name><etal/></person-group><article-title>Role of zinc in human islet amyloid polypeptide aggregation</article-title><source><italic>Journal of the American Chemical Society</italic></source><year>2010</year><volume>132</volume><issue>26</issue><fpage>8973</fpage><lpage>8983</lpage><pub-id pub-id-type="doi">10.1021/ja1007867</pub-id><pub-id pub-id-type="other">2-s2.0-77954269081</pub-id><pub-id pub-id-type="pmid">20536124</pub-id></element-citation></ref><ref id="B99"><label>99</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brender</surname><given-names>J. R.</given-names></name><name><surname>Krishnamoorthy</surname><given-names>J.</given-names></name><name><surname>Messina</surname><given-names>G. M. L.</given-names></name><etal/></person-group><article-title>Zinc stabilization of prefibrillar oligomers of human islet amyloid polypeptide</article-title><source><italic>Chemical Communications</italic></source><year>2013</year><volume>49</volume><issue>32</issue><fpage>3339</fpage><lpage>3341</lpage><pub-id pub-id-type="doi">10.1039/c3cc40383a</pub-id><pub-id pub-id-type="other">2-s2.0-84876564369</pub-id><pub-id pub-id-type="pmid">23505632</pub-id></element-citation></ref><ref id="B100"><label>100</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rutter</surname><given-names>G. A.</given-names></name><name><surname>Chimienti</surname><given-names>F.</given-names></name></person-group><article-title>SLC30A8 mutations in type 2 diabetes</article-title><source><italic>Diabetologia</italic></source><year>2015</year><volume>58</volume><issue>1</issue><fpage>31</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.1007/s00125-014-3405-7</pub-id><pub-id pub-id-type="pmid">25287711</pub-id></element-citation></ref><ref id="B101"><label>101</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sladek</surname><given-names>R.</given-names></name><name><surname>Rocheleau</surname><given-names>G.</given-names></name><name><surname>Rung</surname><given-names>J.</given-names></name><etal/></person-group><article-title>A genome-wide association study identifies novel risk loci for type 2 diabetes</article-title><source><italic>Nature</italic></source><year>2007</year><volume>445</volume><issue>7130</issue><fpage>881</fpage><lpage>885</lpage><pub-id pub-id-type="doi">10.1038/nature05616</pub-id><pub-id pub-id-type="other">2-s2.0-33847176604</pub-id><pub-id pub-id-type="pmid">17293876</pub-id></element-citation></ref><ref id="B102"><label>102</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aspinwall</surname><given-names>C. A.</given-names></name><name><surname>Brooks</surname><given-names>S. A.</given-names></name><name><surname>Kennedy</surname><given-names>R. T.</given-names></name><name><surname>Lakey</surname><given-names>J. R. T.</given-names></name></person-group><article-title>Effects of intravesicular H<sup>+</sup> and extracellular H<sup>+</sup> and Zn<sup>2+</sup> on insulin secretion in pancreatic beta cells</article-title><source><italic>The Journal of Biological Chemistry</italic></source><year>1997</year><volume>272</volume><issue>50</issue><fpage>31308</fpage><lpage>31314</lpage><pub-id pub-id-type="doi">10.1074/jbc.272.50.31308</pub-id><pub-id pub-id-type="other">2-s2.0-0031468583</pub-id><pub-id pub-id-type="pmid">9395458</pub-id></element-citation></ref><ref id="B103"><label>103</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salamekh</surname><given-names>S.</given-names></name><name><surname>Brender</surname><given-names>J. R.</given-names></name><name><surname>Hyung</surname><given-names>S.-J.</given-names></name><etal/></person-group><article-title>A two-site mechanism for the inhibition of IAPP amyloidogenesis by zinc</article-title><source><italic>Journal of Molecular Biology</italic></source><year>2011</year><volume>410</volume><issue>2</issue><fpage>294</fpage><lpage>306</lpage><pub-id pub-id-type="doi">10.1016/j.jmb.2011.05.015</pub-id><pub-id pub-id-type="other">2-s2.0-79958754561</pub-id><pub-id pub-id-type="pmid">21616080</pub-id></element-citation></ref><ref id="B104"><label>104</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ward</surname><given-names>B.</given-names></name><name><surname>Walker</surname><given-names>K.</given-names></name><name><surname>Exley</surname><given-names>C.</given-names></name></person-group><article-title>Copper(II) inhibits the formation of amylin amyloid in vitro</article-title><source><italic>Journal of Inorganic Biochemistry</italic></source><year>2008</year><volume>102</volume><issue>2</issue><fpage>371</fpage><lpage>375</lpage><pub-id pub-id-type="other">2-s2.0-38149065395</pub-id><pub-id pub-id-type="doi">10.1016/j.jinorgbio.2007.09.010</pub-id><pub-id pub-id-type="pmid">18022240</pub-id></element-citation></ref><ref id="B105"><label>105</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marek</surname><given-names>P. J.</given-names></name><name><surname>Patsalo</surname><given-names>V.</given-names></name><name><surname>Green</surname><given-names>D. F.</given-names></name><name><surname>Raleigh</surname><given-names>D. P.</given-names></name></person-group><article-title>Ionic strength effects on amyloid formation by amylin are a complicated interplay among debye screening, ion selectivity, and hofmeister effects</article-title><source><italic>Biochemistry</italic></source><year>2012</year><volume>51</volume><issue>43</issue><fpage>8478</fpage><lpage>8490</lpage><pub-id pub-id-type="doi">10.1021/bi300574r</pub-id><pub-id pub-id-type="other">2-s2.0-84868159835</pub-id><pub-id pub-id-type="pmid">23016872</pub-id></element-citation></ref><ref id="B106"><label>106</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guan</surname><given-names>J.</given-names></name><name><surname>Zhao</surname><given-names>H.-L.</given-names></name><name><surname>Sui</surname><given-names>Y.</given-names></name><etal/></person-group><article-title>Histopathological correlations of islet amyloidosis with apolipoprotein e polymorphisms in type 2 diabetic chinese patients</article-title><source><italic>Pancreas</italic></source><year>2013</year><volume>42</volume><issue>7</issue><fpage>1129</fpage><lpage>1137</lpage><pub-id pub-id-type="other">2-s2.0-84885174282</pub-id><pub-id pub-id-type="doi">10.1097/mpa.0b013e3182965e6e</pub-id><pub-id pub-id-type="pmid">24005233</pub-id></element-citation></ref><ref id="B107"><label>107</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Charge</surname><given-names>S. B.</given-names></name><name><surname>Esiri</surname><given-names>M. M.</given-names></name><name><surname>Bethune</surname><given-names>C. A.</given-names></name><name><surname>Hansen</surname><given-names>B. C.</given-names></name><name><surname>Clark</surname><given-names>A.</given-names></name></person-group><article-title>Apolipoprotein E is associated with islet amyloid and other amyloidoses: implications for Alzheimer's disease</article-title><source><italic>The Journal of Pathology</italic></source><year>1996</year><volume>179</volume><issue>4</issue><fpage>443</fpage><lpage>447</lpage><pub-id pub-id-type="doi">10.1002/(sici)1096-9896(199608)179:460;443::aid-path61262;3.0.co;2-7</pub-id><pub-id pub-id-type="pmid">8869295</pub-id></element-citation></ref><ref id="B108"><label>108</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bales</surname><given-names>K. R.</given-names></name><name><surname>Dodart</surname><given-names>J. C.</given-names></name><name><surname>DeMattos</surname><given-names>R. B.</given-names></name><name><surname>Holtzman</surname><given-names>D. M.</given-names></name><name><surname>Paul</surname><given-names>S. M.</given-names></name></person-group><article-title>Apolipoprotein E, amyloid, and Alzheimer disease</article-title><source><italic>Molecular Interventions</italic></source><year>2002</year><volume>2</volume><issue>6</issue><fpage>363</fpage><lpage>375</lpage><pub-id pub-id-type="other">2-s2.0-0345072821</pub-id><pub-id pub-id-type="doi">10.1124/mi.2.6.363</pub-id><pub-id pub-id-type="pmid">14993413</pub-id></element-citation></ref><ref id="B109"><label>109</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vidal</surname><given-names>J.</given-names></name><name><surname>Verchere</surname><given-names>C. B.</given-names></name><name><surname>Andrikopoulos</surname><given-names>S.</given-names></name><etal/></person-group><article-title>The effect of apolipoprotein E deficiency on islet amyloid deposition in human islet amyloid polypeptide transgenic mice</article-title><source><italic>Diabetologia</italic></source><year>2003</year><volume>46</volume><issue>1</issue><fpage>71</fpage><lpage>79</lpage><pub-id pub-id-type="other">2-s2.0-0037281013</pub-id><pub-id pub-id-type="pmid">12637985</pub-id></element-citation></ref><ref id="B110"><label>110</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lei</surname><given-names>P.</given-names></name><name><surname>Wu</surname><given-names>W.-H.</given-names></name><name><surname>Li</surname><given-names>R.-W.</given-names></name><etal/></person-group><article-title>Prevention and promotion effects of apolipoprotein E4 on amylin aggregation</article-title><source><italic>Biochemical and Biophysical Research Communications</italic></source><year>2008</year><volume>368</volume><issue>2</issue><fpage>414</fpage><lpage>418</lpage><pub-id pub-id-type="other">2-s2.0-39549105812</pub-id><pub-id pub-id-type="doi">10.1016/j.bbrc.2008.01.103</pub-id><pub-id pub-id-type="pmid">18243137</pub-id></element-citation></ref><ref id="B111"><label>111</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Westermark</surname><given-names>P.</given-names></name><name><surname>Li</surname><given-names>Z.-C.</given-names></name><name><surname>Westermark</surname><given-names>G. T.</given-names></name><name><surname>Leckstr&#246;m</surname><given-names>A.</given-names></name><name><surname>Steiner</surname><given-names>D. F.</given-names></name></person-group><article-title>Effects of beta cell granule components on human islet amyloid polypeptide fibril formation</article-title><source><italic>FEBS Letters</italic></source><year>1996</year><volume>379</volume><issue>3</issue><fpage>203</fpage><lpage>206</lpage><pub-id pub-id-type="doi">10.1016/0014-5793(95)01512-4</pub-id><pub-id pub-id-type="other">2-s2.0-0030025653</pub-id><pub-id pub-id-type="pmid">8603689</pub-id></element-citation></ref><ref id="B112"><label>112</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gilead</surname><given-names>S.</given-names></name><name><surname>Wolfenson</surname><given-names>H.</given-names></name><name><surname>Gazit</surname><given-names>E.</given-names></name></person-group><article-title>Molecular mapping of the recognition interface between the islet amyloid polypeptide and insulin</article-title><source><italic>Angewandte Chemie&#8212;International Edition</italic></source><year>2006</year><volume>45</volume><issue>39</issue><fpage>6476</fpage><lpage>6480</lpage><pub-id pub-id-type="other">2-s2.0-33749830133</pub-id><pub-id pub-id-type="doi">10.1002/anie.200602034</pub-id><pub-id pub-id-type="pmid">16960910</pub-id></element-citation></ref><ref id="B113"><label>113</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Susa</surname><given-names>A. C.</given-names></name><name><surname>Wu</surname><given-names>C.</given-names></name><name><surname>Bernstein</surname><given-names>S. L.</given-names></name><etal/></person-group><article-title>Defining the molecular basis of amyloid inhibitors: human islet amyloid polypeptide-insulin interactions</article-title><source><italic>Journal of the American Chemical Society</italic></source><year>2014</year><volume>136</volume><issue>37</issue><fpage>12912</fpage><lpage>12919</lpage><pub-id pub-id-type="doi">10.1021/ja504031d</pub-id><pub-id pub-id-type="pmid">25144879</pub-id></element-citation></ref><ref id="B114"><label>114</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Engel</surname><given-names>M. F. M.</given-names></name><name><surname>Khemt&#233;mourian</surname><given-names>L.</given-names></name><name><surname>Kleijer</surname><given-names>C. C.</given-names></name><etal/></person-group><article-title>Membrane damage by human islet amyloid polypeptide through fibril growth at the membrane</article-title><source><italic>Proceedings of the National Academy of Sciences of the United States of America</italic></source><year>2008</year><volume>105</volume><issue>16</issue><fpage>6033</fpage><lpage>6038</lpage><pub-id pub-id-type="doi">10.1073/pnas.0708354105</pub-id><pub-id pub-id-type="other">2-s2.0-43149118349</pub-id><pub-id pub-id-type="pmid">18408164</pub-id></element-citation></ref><ref id="B115"><label>115</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Janciauskiene</surname><given-names>S.</given-names></name><name><surname>Ahr&#233;n</surname><given-names>B.</given-names></name></person-group><article-title>Fibrillar islet amyloid polypeptide differentially affects oxidative mechanisms and lipoprotein uptake in correlation with cytotoxicity in two insulin-producing cell lines</article-title><source><italic>Biochemical and Biophysical Research Communications</italic></source><year>2000</year><volume>267</volume><issue>2</issue><fpage>619</fpage><lpage>625</lpage><pub-id pub-id-type="doi">10.1006/bbrc.1999.1989</pub-id><pub-id pub-id-type="other">2-s2.0-0034684963</pub-id><pub-id pub-id-type="pmid">10631112</pub-id></element-citation></ref><ref id="B116"><label>116</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lorenzo</surname><given-names>A.</given-names></name><name><surname>Razzaboni</surname><given-names>B.</given-names></name><name><surname>Weir</surname><given-names>G. C.</given-names></name><name><surname>Yankner</surname><given-names>B. A.</given-names></name></person-group><article-title>Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus</article-title><source><italic>Nature</italic></source><year>1994</year><volume>368</volume><issue>6473</issue><fpage>756</fpage><lpage>760</lpage><pub-id pub-id-type="other">2-s2.0-0028303844</pub-id><pub-id pub-id-type="doi">10.1038/368756a0</pub-id><pub-id pub-id-type="pmid">8152488</pub-id></element-citation></ref><ref id="B117"><label>117</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meier</surname><given-names>J. J.</given-names></name><name><surname>Kayed</surname><given-names>R.</given-names></name><name><surname>Lin</surname><given-names>C.-Y.</given-names></name><etal/></person-group><article-title>Inhibition of human IAPP fibril formation does not prevent <italic>&#946;</italic>-cell death: evidence for distinct actions of oligomers and fibrils of human IAPP</article-title><source><italic>American Journal of Physiology&#8212;Endocrinology and Metabolism</italic></source><year>2006</year><volume>291</volume><issue>6</issue><fpage>E1317</fpage><lpage>E1324</lpage><pub-id pub-id-type="doi">10.1152/ajpendo.00082.2006</pub-id><pub-id pub-id-type="other">2-s2.0-33845467504</pub-id><pub-id pub-id-type="pmid">16849627</pub-id></element-citation></ref><ref id="B118"><label>118</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Janson</surname><given-names>J.</given-names></name><name><surname>Soeller</surname><given-names>W. C.</given-names></name><name><surname>Roche</surname><given-names>P. C.</given-names></name><etal/></person-group><article-title>Spontaneous diabetes mellitus in transgenic mice expressing human islet amyloid polypeptide</article-title><source><italic>Proceedings of the National Academy of Sciences of the United States of America</italic></source><year>1996</year><volume>93</volume><issue>14</issue><fpage>7283</fpage><lpage>7288</lpage><pub-id pub-id-type="doi">10.1073/pnas.93.14.7283</pub-id><pub-id pub-id-type="other">2-s2.0-0029901739</pub-id><pub-id pub-id-type="pmid">8692984</pub-id></element-citation></ref><ref id="B119"><label>119</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bram</surname><given-names>Y.</given-names></name><name><surname>Frydman-Marom</surname><given-names>A.</given-names></name><name><surname>Yanai</surname><given-names>I.</given-names></name><etal/></person-group><article-title>Apoptosis induced by islet amyloid polypeptide soluble oligomers is neutralized by diabetes-associated specific antibodies</article-title><source><italic>Scientific Reports</italic></source><year>2014</year><volume>4, article 4267</volume><pub-id pub-id-type="doi">10.1038/srep04267</pub-id><pub-id pub-id-type="other">2-s2.0-84897795266</pub-id></element-citation></ref><ref id="B120"><label>120</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Janson</surname><given-names>J.</given-names></name><name><surname>Ashley</surname><given-names>R. H.</given-names></name><name><surname>Harrison</surname><given-names>D.</given-names></name><name><surname>McIntyre</surname><given-names>S.</given-names></name><name><surname>Butler</surname><given-names>P. C.</given-names></name></person-group><article-title>The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles</article-title><source><italic>Diabetes</italic></source><year>1999</year><volume>48</volume><issue>3</issue><fpage>491</fpage><lpage>498</lpage><pub-id pub-id-type="doi">10.2337/diabetes.48.3.491</pub-id><pub-id pub-id-type="other">2-s2.0-0033048453</pub-id><pub-id pub-id-type="pmid">10078548</pub-id></element-citation></ref><ref id="B121"><label>121</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pillay</surname><given-names>K.</given-names></name><name><surname>Govender</surname><given-names>P.</given-names></name></person-group><article-title>Amylin uncovered: a review on the polypeptide responsible for type II diabetes</article-title><source><italic>BioMed Research International</italic></source><year>2013</year><volume>2013</volume><fpage>17</fpage><pub-id pub-id-type="publisher-id">826706</pub-id><pub-id pub-id-type="other">2-s2.0-84877301983</pub-id><pub-id pub-id-type="doi">10.1155/2013/826706</pub-id></element-citation></ref><ref id="B122"><label>122</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abedini</surname><given-names>A.</given-names></name><name><surname>Schmidt</surname><given-names>A. M.</given-names></name></person-group><article-title>Mechanisms of islet amyloidosis toxicity in type 2 diabetes</article-title><source><italic>FEBS Letters</italic></source><year>2013</year><volume>587</volume><issue>8</issue><fpage>1119</fpage><lpage>1127</lpage><pub-id pub-id-type="doi">10.1016/j.febslet.2013.01.017</pub-id><pub-id pub-id-type="other">2-s2.0-84876021115</pub-id><pub-id pub-id-type="pmid">23337872</pub-id></element-citation></ref><ref id="B123"><label>123</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caillon</surname><given-names>L.</given-names></name><name><surname>Lequin</surname><given-names>O.</given-names></name><name><surname>Khemt&#233;mourian</surname><given-names>L.</given-names></name></person-group><article-title>Evaluation of membrane models and their composition for islet amyloid polypeptide-membrane aggregation</article-title><source><italic>Biochimica et Biophysica Acta</italic></source><year>2013</year><volume>1828</volume><issue>9</issue><fpage>2091</fpage><lpage>2098</lpage><pub-id pub-id-type="doi">10.1016/j.bbamem.2013.05.014</pub-id><pub-id pub-id-type="other">2-s2.0-84879231527</pub-id><pub-id pub-id-type="pmid">23707907</pub-id></element-citation></ref><ref id="B124"><label>124</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mirzabekov</surname><given-names>T. A.</given-names></name><name><surname>Lin</surname><given-names>M.-C.</given-names></name><name><surname>Kagan</surname><given-names>B. L.</given-names></name></person-group><article-title>Pore formation by the cytotoxic islet amyloid peptide amylin</article-title><source><italic>The Journal of Biological Chemistry</italic></source><year>1996</year><volume>271</volume><issue>4</issue><fpage>1988</fpage><lpage>1992</lpage><pub-id pub-id-type="doi">10.1074/jbc.271.4.1988</pub-id><pub-id pub-id-type="other">2-s2.0-0030044018</pub-id><pub-id pub-id-type="pmid">8567648</pub-id></element-citation></ref><ref id="B125"><label>125</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fawthrop</surname><given-names>D. J.</given-names></name><name><surname>Boobis</surname><given-names>A. R.</given-names></name><name><surname>Davies</surname><given-names>D. S.</given-names></name></person-group><article-title>Mechanisms of cell death</article-title><source><italic>Archives of Toxicology</italic></source><year>1991</year><volume>65</volume><issue>6</issue><fpage>437</fpage><lpage>444</lpage><pub-id pub-id-type="doi">10.1007/bf01977355</pub-id><pub-id pub-id-type="other">2-s2.0-0025861927</pub-id><pub-id pub-id-type="pmid">1929863</pub-id></element-citation></ref><ref id="B126"><label>126</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Orrenius</surname><given-names>S.</given-names></name><name><surname>McCabe</surname><given-names>M. J.</given-names><suffix>Jr.</suffix></name><name><surname>Nicotera</surname><given-names>P.</given-names></name></person-group><article-title>Ca<sup>2+</sup>-dependent mechanisms of cytotoxicity and programmed cell death</article-title><source><italic>Toxicology Letters</italic></source><year>1992</year><volume>64-65</volume><fpage>357</fpage><lpage>364</lpage><pub-id pub-id-type="doi">10.1016/0378-4274(92)90208-2</pub-id><pub-id pub-id-type="other">2-s2.0-3242666765</pub-id><pub-id pub-id-type="pmid">1335178</pub-id></element-citation></ref><ref id="B127"><label>127</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>S.</given-names></name><name><surname>Liu</surname><given-names>J.</given-names></name><name><surname>Saafi</surname><given-names>E. L.</given-names></name><name><surname>Cooper</surname><given-names>G. J. S.</given-names></name></person-group><article-title>Induction of apoptosis by human amylin in RINm5F islet <italic>&#946;</italic>-cells is associated with enhanced expression of p53 and p21<sup>WAF1/CIP1</sup>
</article-title><source><italic>FEBS Letters</italic></source><year>1999</year><volume>455</volume><issue>3</issue><fpage>315</fpage><lpage>320</lpage><pub-id pub-id-type="doi">10.1016/s0014-5793(99)00894-7</pub-id><pub-id pub-id-type="other">2-s2.0-0032800544</pub-id><pub-id pub-id-type="pmid">10437796</pub-id></element-citation></ref><ref id="B128"><label>128</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mlynarczyk</surname><given-names>C.</given-names></name><name><surname>Fahraeus</surname><given-names>R.</given-names></name></person-group><article-title>Endoplasmic reticulum stress sensitizes cells to DNA damage-induced apoptosis through p53-dependent suppression of p21(CDKN1A.)</article-title><source><italic>Nature Communications</italic></source><year>2014</year><volume>5, article 5067</volume><pub-id pub-id-type="doi">10.1038/ncomms6067</pub-id></element-citation></ref><ref id="B129"><label>129</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>Y. J.</given-names></name><name><surname>Lee</surname><given-names>S.</given-names></name><name><surname>Kieffer</surname><given-names>T. J.</given-names></name><etal/></person-group><article-title>Deletion of Fas protects islet beta cells from cytotoxic effects of human islet amyloid polypeptide</article-title><source><italic>Diabetologia</italic></source><year>2012</year><volume>55</volume><issue>4</issue><fpage>1035</fpage><lpage>1047</lpage><pub-id pub-id-type="other">2-s2.0-84862826030</pub-id><pub-id pub-id-type="doi">10.1007/s00125-012-2451-2</pub-id></element-citation></ref><ref id="B130"><label>130</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>X.-L.</given-names></name><name><surname>Xu</surname><given-names>G.</given-names></name><name><surname>Chen</surname><given-names>T.</given-names></name><etal/></person-group><article-title>Phycocyanin protects INS-1E pancreatic beta cells against human islet amyloid polypeptide-induced apoptosis through attenuating oxidative stress and modulating JNK and p38 mitogen-activated protein kinase pathways</article-title><source><italic>International Journal of Biochemistry and Cell Biology</italic></source><year>2009</year><volume>41</volume><issue>7</issue><fpage>1526</fpage><lpage>1535</lpage><pub-id pub-id-type="doi">10.1016/j.biocel.2009.01.002</pub-id><pub-id pub-id-type="other">2-s2.0-63049115697</pub-id><pub-id pub-id-type="pmid">19166964</pub-id></element-citation></ref><ref id="B131"><label>131</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zraika</surname><given-names>S.</given-names></name><name><surname>Hull</surname><given-names>R. L.</given-names></name><name><surname>Udayasankar</surname><given-names>J.</given-names></name><etal/></person-group><article-title>Oxidative stress is induced by islet amyloid formation and time-dependently mediates amyloid-induced beta cell apoptosis</article-title><source><italic>Diabetologia</italic></source><year>2009</year><volume>52</volume><issue>4</issue><fpage>626</fpage><lpage>635</lpage><pub-id pub-id-type="other">2-s2.0-61449123871</pub-id><pub-id pub-id-type="doi">10.1007/s00125-008-1255-x</pub-id><pub-id pub-id-type="pmid">19148619</pub-id></element-citation></ref><ref id="B132"><label>132</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gedulin</surname><given-names>B.</given-names></name><name><surname>Cooper</surname><given-names>G. J. S.</given-names></name><name><surname>Young</surname><given-names>A. A.</given-names></name></person-group><article-title>Amylin secretion from the perfused pancreas: dissociation from insulin and abnormal elevation in insulin-resistant diabetic rats</article-title><source><italic>Biochemical and Biophysical Research Communications</italic></source><year>1991</year><volume>180</volume><issue>2</issue><fpage>782</fpage><lpage>789</lpage><pub-id pub-id-type="doi">10.1016/s0006-291x(05)81133-7</pub-id><pub-id pub-id-type="other">2-s2.0-0025824715</pub-id><pub-id pub-id-type="pmid">1953751</pub-id></element-citation></ref><ref id="B133"><label>133</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>C.-J.</given-names></name><name><surname>Lin</surname><given-names>C.-Y.</given-names></name><name><surname>Haataja</surname><given-names>L.</given-names></name><etal/></person-group><article-title>High expression rates of human islet amyloid polypeptide induce endoplasmic reticulum stress-mediated <italic>&#946;</italic>-cell apoptosis, a characteristic of humans with type 2 but not type 1 diabetes</article-title><source><italic>Diabetes</italic></source><year>2007</year><volume>56</volume><issue>8</issue><fpage>2016</fpage><lpage>2027</lpage><pub-id pub-id-type="doi">10.2337/db07-0197</pub-id><pub-id pub-id-type="other">2-s2.0-34547638958</pub-id><pub-id pub-id-type="pmid">17475933</pub-id></element-citation></ref><ref id="B134"><label>134</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>C.-J.</given-names></name><name><surname>Haataja</surname><given-names>L.</given-names></name><name><surname>Gurlo</surname><given-names>T.</given-names></name><etal/></person-group><article-title>Induction of endoplasmic reticulum stress-induced beta-cell apoptosis and accumulation of polyubiquitinated proteins by human islet amyloid polypeptide</article-title><source><italic>The American Journal of Physiology&#8212;Endocrinology and Metabolism</italic></source><year>2007</year><volume>293</volume><issue>6</issue><fpage>E1656</fpage><lpage>E1662</lpage><pub-id pub-id-type="doi">10.1152/ajpendo.00318.2007</pub-id><pub-id pub-id-type="other">2-s2.0-37149012111</pub-id><pub-id pub-id-type="pmid">17911343</pub-id></element-citation></ref><ref id="B135"><label>135</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shigihara</surname><given-names>N.</given-names></name><name><surname>Fukunaka</surname><given-names>A.</given-names></name><name><surname>Hara</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Human IAPP-induced pancreatic <italic>&#946;</italic> cell toxicity and its regulation by autophagy</article-title><source><italic>The Journal of Clinical Investigation</italic></source><year>2014</year><volume>124</volume><issue>8</issue><fpage>3634</fpage><lpage>3644</lpage><pub-id pub-id-type="doi">10.1172/jci69866</pub-id><pub-id pub-id-type="pmid">25036706</pub-id></element-citation></ref><ref id="B136"><label>136</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Esko</surname><given-names>J. D.</given-names></name><name><surname>Stewart</surname><given-names>T. E.</given-names></name><name><surname>Taylor</surname><given-names>W. H.</given-names></name></person-group><article-title>Animal cell mutants defective in glycosaminoglycan biosynthesis</article-title><source><italic>Proceedings of the National Academy of Sciences of the United States of America</italic></source><year>1985</year><volume>82</volume><issue>10</issue><fpage>3197</fpage><lpage>3201</lpage><pub-id pub-id-type="doi">10.1073/pnas.82.10.3197</pub-id><pub-id pub-id-type="other">2-s2.0-2142854239</pub-id><pub-id pub-id-type="pmid">3858816</pub-id></element-citation></ref><ref id="B137"><label>137</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sandwall</surname><given-names>E.</given-names></name><name><surname>O'Callaghan</surname><given-names>P.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Lindahl</surname><given-names>U.</given-names></name><name><surname>Lannfelt</surname><given-names>L.</given-names></name><name><surname>Li</surname><given-names>J.-P.</given-names></name></person-group><article-title>Heparan sulfate mediates amyloid-beta internalization and cytotoxicity</article-title><source><italic>Glycobiology</italic></source><year>2010</year><volume>20</volume><issue>5</issue><fpage>533</fpage><lpage>541</lpage><pub-id pub-id-type="doi">10.1093/glycob/cwp205</pub-id><pub-id pub-id-type="other">2-s2.0-77952872366</pub-id><pub-id pub-id-type="pmid">20053627</pub-id></element-citation></ref><ref id="B138"><label>138</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saridaki</surname><given-names>T.</given-names></name><name><surname>Zampagni</surname><given-names>M.</given-names></name><name><surname>Mannini</surname><given-names>B.</given-names></name><etal/></person-group><article-title>Glycosaminoglycans (GAGs) suppress the toxicity of HypF-N prefibrillar aggregates</article-title><source><italic>Journal of Molecular Biology</italic></source><year>2012</year><volume>421</volume><issue>4-5</issue><fpage>616</fpage><lpage>630</lpage><pub-id pub-id-type="other">2-s2.0-84864284188</pub-id><pub-id pub-id-type="doi">10.1016/j.jmb.2012.02.007</pub-id><pub-id pub-id-type="pmid">22326346</pub-id></element-citation></ref><ref id="B139"><label>139</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Evangelisti</surname><given-names>E.</given-names></name><name><surname>Cecchi</surname><given-names>C.</given-names></name><name><surname>Cascella</surname><given-names>R.</given-names></name><etal/></person-group><article-title>Membrane lipid composition and its physicochemical properties define cell vulnerability to aberrant protein oligomers</article-title><source><italic>Journal of Cell Science</italic></source><year>2012</year><volume>125</volume><issue>10</issue><fpage>2416</fpage><lpage>2427</lpage><pub-id pub-id-type="doi">10.1242/jcs.098434</pub-id><pub-id pub-id-type="other">2-s2.0-84864810728</pub-id><pub-id pub-id-type="pmid">22344258</pub-id></element-citation></ref><ref id="B140"><label>140</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trikha</surname><given-names>S.</given-names></name><name><surname>Jeremic</surname><given-names>A. M.</given-names></name></person-group><article-title>Clustering and internalization of toxic amylin oligomers in pancreatic cells require plasma membrane cholesterol</article-title><source><italic>The Journal of Biological Chemistry</italic></source><year>2011</year><volume>286</volume><issue>41</issue><fpage>36086</fpage><lpage>36097</lpage><pub-id pub-id-type="doi">10.1074/jbc.m111.240762</pub-id><pub-id pub-id-type="other">2-s2.0-80053898059</pub-id><pub-id pub-id-type="pmid">21865171</pub-id></element-citation></ref><ref id="B141"><label>141</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calamai</surname><given-names>M.</given-names></name><name><surname>Pavone</surname><given-names>F. S.</given-names></name></person-group><article-title>Partitioning and confinement of GM1 ganglioside induced by amyloid aggregates</article-title><source><italic>FEBS Letters</italic></source><year>2013</year><volume>587</volume><issue>9</issue><fpage>1385</fpage><lpage>1391</lpage><pub-id pub-id-type="doi">10.1016/j.febslet.2013.03.014</pub-id><pub-id pub-id-type="other">2-s2.0-84876472619</pub-id><pub-id pub-id-type="pmid">23523632</pub-id></element-citation></ref><ref id="B142"><label>142</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sciacca</surname><given-names>M. F. M.</given-names></name><name><surname>Brender</surname><given-names>J. R.</given-names></name><name><surname>Lee</surname><given-names>D.-K.</given-names></name><name><surname>Ramamoorthy</surname><given-names>A.</given-names></name></person-group><article-title>Phosphatidylethanolamine enhances amyloid fiber-dependent membrane fragmentation</article-title><source><italic>Biochemistry</italic></source><year>2012</year><volume>51</volume><issue>39</issue><fpage>7676</fpage><lpage>7684</lpage><pub-id pub-id-type="doi">10.1021/bi3009888</pub-id><pub-id pub-id-type="other">2-s2.0-84867091546</pub-id><pub-id pub-id-type="pmid">22970795</pub-id></element-citation></ref><ref id="B143"><label>143</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>E. C.</given-names></name><name><surname>Ha</surname><given-names>E.</given-names></name><name><surname>Singh</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Copper(II)-human amylin complex protects pancreatic cells from amylin toxicity</article-title><source><italic>Physical Chemistry Chemical Physics</italic></source><year>2013</year><volume>15</volume><issue>30</issue><fpage>12558</fpage><lpage>12571</lpage><pub-id pub-id-type="doi">10.1039/c3cp44542a</pub-id><pub-id pub-id-type="other">2-s2.0-84881148850</pub-id><pub-id pub-id-type="pmid">23793354</pub-id></element-citation></ref><ref id="B144"><label>144</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hebda</surname><given-names>J. A.</given-names></name><name><surname>Magzoub</surname><given-names>M.</given-names></name><name><surname>Miranker</surname><given-names>A. D.</given-names></name></person-group><article-title>Small molecule screening in context: lipid-catalyzed amyloid formation</article-title><source><italic>Protein Science</italic></source><year>2014</year><volume>23</volume><issue>10</issue><fpage>1341</fpage><lpage>1348</lpage><pub-id pub-id-type="doi">10.1002/pro.2518</pub-id><pub-id pub-id-type="pmid">25043951</pub-id></element-citation></ref><ref id="B145"><label>145</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Raleigh</surname><given-names>D. P.</given-names></name></person-group><article-title>The ability of insulin to inhibit the formation of amyloid by pro-islet amyloid polypeptide processing intermediates is significantly reduced in the presence of sulfated glycosaminoglycans</article-title><source><italic>Biochemistry</italic></source><year>2014</year><volume>53</volume><issue>16</issue><fpage>2605</fpage><lpage>2614</lpage><pub-id pub-id-type="other">2-s2.0-84899650412</pub-id><pub-id pub-id-type="doi">10.1021/bi4015488</pub-id><pub-id pub-id-type="pmid">24654599</pub-id></element-citation></ref><ref id="B146"><label>146</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hebda</surname><given-names>J. A.</given-names></name><name><surname>Saraogi</surname><given-names>I.</given-names></name><name><surname>Magzoub</surname><given-names>M.</given-names></name><name><surname>Hamilton</surname><given-names>A. D.</given-names></name><name><surname>Miranker</surname><given-names>A. D.</given-names></name></person-group><article-title>A peptidomimetic approach to targeting pre-amyloidogenic states in type II diabetes</article-title><source><italic>Chemistry &amp; Biology</italic></source><year>2009</year><volume>16</volume><issue>9</issue><fpage>943</fpage><lpage>950</lpage><pub-id pub-id-type="doi">10.1016/j.chembiol.2009.08.013</pub-id><pub-id pub-id-type="other">2-s2.0-70349165341</pub-id><pub-id pub-id-type="pmid">19778722</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="fig1" orientation="portrait" position="float"><label>Figure 1</label><caption><p>(a) Comparison of amino acid sequences of IAPP from different species. Residues that differ to those of human are indicated in red bold whereas the human 20&#8211;29 amyloidogenic segment is represented in bold blue. (b) Schematic ribbon representation of sodium dodecyl sulfate micelle-bound IAPP secondary structure (PDB code: 2KB8).</p></caption><graphic xlink:href="JDR2015-515307.001"/></fig><fig id="fig2" orientation="portrait" position="float"><label>Figure 2</label><caption><p>(a) Representative tapping mode atomic force microscopy image (amplitude mode) of IAPP amyloid fibrils prepared in homogenous solution (50&#8201;<italic>&#956;</italic>M at 37&#176;C for 24&#8201;h.). (b) Schematic representation of the general cross-<italic>&#946;</italic>-sheet quaternary structure of amyloids showing the interstrand (<italic>&#8773;</italic>4.7&#8201;&#197;) and intersheet (<italic>&#8773;</italic>10&#8201;&#197;) distances.</p></caption><graphic xlink:href="JDR2015-515307.002"/></fig><fig id="fig3" orientation="portrait" position="float"><label>Figure 3</label><caption><p>Roles of sulfated GAGs in IAPP amyloidogenesis. (a) Representative structure of heparin or heparan sulfate composed of glucuronic acid (GlcA) linked to glucosamine (GlcN) disaccharide repeating subunit. R<sub>1</sub> could be &#8211;H or &#8211;SO<sub>3</sub>
<sup>&#8722;</sup> whereas R<sub>2</sub> could be &#8211;H, &#8211;SO<sub>3</sub>
<sup>&#8722;</sup>, or &#8211;COCH<sub>3</sub>. (b) Schematic representation of the postulated mechanism by which sulfated GAGs might promote IAPP amyloid formation. The positively charged N-terminal domain of IAPP binds to the sulfate moieties of GAGs by means of electrostatic interactions. This binding event triggers the formation of a <italic>&#945;</italic>-helix (represented as a cylinder). This generates a high local concentration of peptide on the GAG scaffold that drives the association of IAPP amyloidogenic C-terminal segment, which has a high propensity to adopt a <italic>&#946;</italic>-sheet (represented as an arrow). This drastically accelerates the formation of <italic>&#946;</italic>-sheet rich assemblies.</p></caption><graphic xlink:href="JDR2015-515307.003"/></fig></floats-group></article>